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Abstract 
 
Mechanisms for mutations in RNA viruses include random point mutations, insertions, 
deletions, recombination and re-assortment. Most viruses have more than one of these 
mechanisms operating during their life cycle. Impact of sequence divergence is seen in the areas 
of evolution, epidemiology and ecology of these viruses.  Immediate negative consequences of 
genetic diversity include failure of vaccination, resistance to anti-virals, emergence and re-
emergence of novel virus isolates with increased virulence or altered tropism. To identify 
specific sequence features that influence recombination, a new in-vitro system was developed 
using an infectious cDNA clone of PRRS virus that expressed fluorescent proteins. The in-vitro 
experimental system involved the co-transfection of a pair of closely related PRRSV infectious 
clones: a fully functional non-fluorescent PRRS virus infectious clone that possessed a single 
mutation in a green fluorescent protein (GFP) and a second infectious clone that contained a 
defective fluorescent virus. The readout for successful recombination was appearance of a fully 
functional fluorescent virus. The model system creates the opportunity to study several aspects of 
recombination, including the requirement for sequence homology between viruses undergoing 
recombination. 
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Chapter 1 - Literature review of PRRS virus 
 
 Overview of the dissertation 
 
RNA viruses are known for their rapid rate of mutation and evolution. Point mutations 
result in genetic drift while recombinations have been found to result in genetic shift. 
Recombination in RNA viruses is a more recent area of research as compared to point mutations. 
RNA recombination was first identified in positive-sense RNA animal viruses in the 1960s. It 
was initially thought to occur only in positive-sense RNA viruses, but soon was discovered in 
negative-sense RNA viruses, single & double stranded viruses, multipartite viruses and 
retroviruses as well (Goodrich and Duesberg, 1990; HIRST, 1962; Worobey and Holmes, 1999). 
Starting from animal viruses, recombination has been identified in plant viruses as well as in 
bacteriophages. The consequences of such genetic shifts include species jumps and emergence of 
viruses with altered pathogenicity.   
 
Porcine reproductive and respiratory syndrome virus (PRRSV) is responsible for major 
economic impacts to the swine industry worldwide. One of the biggest challenges in the control 
and elimination of this disease is the rapid evolutionary rate of this RNA virus. Recombination 
has been indicated to be one of the sources of genetic diversity in PRRSV. In this dissertation we 
describe the use of PRRSV as a model virus to develop an in-vitro system to study parameters 
that influence RNA recombination.  
 
Chapter 1 gives relevant background for PRRS virus and a review of the pathogenic 
mechanisms of this virus.  Chapter 2 is a literature review of RNA recombination. Part A in this 
chapter includes background knowledge about the molecular mechanism of recombination: 
‘copy-choice’ mechanism, recombination in other members in Order Nidovirales and systems 
that are used in the study of RNA recombination. Part B in Chapter 2 discusses the current 
information about PRRSV recombination, knowledge gaps and the goal of this study. Chapter 3 
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describes the new in-vitro system that was established in this research project. Chapter 4 
concludes this dissertation with applications of this research in the study of RNA recombination.  
 
 1.A. Background for PRRS virus 
 
According to the USDA Foreign Agricultural Service 2012 statistics, pork is the world’s 
most widely eaten meat, which amounts to 42%, followed by chicken, beef and turkey. United 
States is one of the world’s top ten consumers for pork. Besides meat, hogs also make a 
significant contribution as a source for nearly 20 pharmaceuticals (heart valves, insulin, 
enzymes) and many more consumer products (fertilizers, garments, cosmetics).  Porcine 
reproductive and respiratory (PRRS) has been the most challenging and devastating disease for 
producers since it emerged in early 1980s. According to the latest assessment in 2011, the annual 
production losses to the US swine industry due to PRRS is about $664 million and other 
additional costs associated with the disease is $447 million (Holtkamp et al., 2011; Neumann et 
al., 2005). In the US alone an estimated 60% herds are infected with PRRS virus. This disease 
has been declared to be the biggest economic burden to the swine industry by the National Pork 
Board. An outbreak of PRRS causes respiratory distress in young pigs, reproductive losses in 
adult pigs, increased mortality and overall poor growth performance in a herd (Snijder and 
Spaan, 2007). Within a production system, PRRSV infection predominantly exists as a 
subclinical infection, participating as a co-factor in various polymicrobial disease syndromes, 
such as porcine respiratory disease complex (PRDC) and porcine circovirus associated disease 
(PCVAD). Soon after PRRS virus was first isolated in the Netherlands and United States in the 
late 1980s, it spread throughout the world and is endemic in most swine-producing countries 
(Benfield et al., 1992; Wensvoort et al., 1991). The high rate of morbidity and mortality involves 
severe animal suffering and direct economic impact. In section 1.A. the virus biology, genetic 
divergence and reverse genetics as an effective tool to study PRRSV are described.  This is 
followed by section 1.B. that discusses the pathogenic mechanisms that PRRSV uses to cause 
disease.  
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 1.A.i. PRRS virus: genome organization and replication 
 
PRRS first appeared in Midwestern United States in 1987 followed by similar reports 
from Quebec and Germany (Dea et al., 1992; Hill, H, 1990; Wensvoort et al., 1991). In 1991, the 
etiological agent of PRRS was confirmed to be a positive-sense single-stranded RNA virus 
(Terpstra et al., 1991). Based on nucleotide sequencing and amino acid comparison, PRRSV was 
found to be closely related to lactate dehydrogenase-elevating virus (LDV)  and equine arteritis 
virus (EAV) from the family Arteriviridae (Meng et al., 1994; Meulenberg et al., 1993). Further 
investigation showed that genome organization and expression of this virus had several 
similarities with family Coronaviridae that belonged to the same order, Nidovirales (Cavanagh, 
1997; Snijder and Meulenberg, 1998).  
 
PRRS virus has limited tropism in continuous cell culture; only African green monkey 
kidney cells (MA-104) and derivatives (MARC-145) have been found susceptible to the virus 
(Duan et al., 1998). During infection in swine, target cells are restricted to the monocytic lineage 
and porcine alveolar macrophages (PAMs) are the primary cells that are infected by PRRSV 
(Duan et al., 1997). CD 163 is considered to play a critical role in PRRSV infection as it is 
sufficient to make a cell permissive to this virus (Calvert et al., 2007)(Patton et al., 2009). CD 
163 belongs to the scavenger receptor cysteine-rich (SRCR) superfamily which is a macrophage-
specific receptor. Physiologically CD 163 may be involved in anti-inflammatory responses and 
its expression can be modulated by interlukin-10 (IL-10), M-CSF, GM-CSF and IL-4 (Buechler 
et al., 2000; Moestrup and Møller, 2004). Viral factors that bind with CD 163 have been shown 
to be GP2 and GP4 (Das et al., 2010). These interactions enable internalization and release of the 
virus genome inside the cell. Until recently CD169, a sialoadhesin receptor on porcine 
macrophages was considered essential for the initial binding and entry of PRRSV (Delputte and 
Nauwynck, 2004). Internalization was suggested to occur by CD169 on cell surface binding with 
GP5-M heterodimer on the virion surface. However, it has now been demonstrated in CD169 
knockout pigs that this receptor is not essential for PRRSV infection in pigs  
 
The length of full-length PRRSV genome is approximately 15 kilobases and it differs 
based on strain of the virus (Conzelmann et al., 1993). Lelystad, the prototype Eurpean type 1 
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strain, is 15.1 Kb (GenBank accession number M96262.2) while 16244B, a North American type 
2 strain, is 15.4 Kb (GenBank accession number: AF046869.1) in length. As the genomic RNA 
is positive-stranded it is capable of being directly translated by the host protein synthesis 
machinery and hence the virus does not have to carry the RNA polymerase in its virion. The 
genomic RNA has a 5’ cap and a 3’ polyadenylated tail (Meulenberg et al., 1993; J. J. M. 
Meulenberg et al., 1998). 5’ and 3’ ends carry 190-220 nt and 59-117 nt respectively of 
untranslated regions that flank the polycistronic RNA (Lu et al., 2011; Snijder and Meulenberg, 
1998). 5’UTR plays a crucial role in virus replication and translation mechanisms (van den Born 
et al., 2005).  
 
The PRRS virus genome contains at least ten open reading frames (ORFs) comprising 14 
non-structural protein and 8 structural protein coding regions (Fang and Snijder, 2010; Johnson 
et al., 2011a). The non-structural protein (Nsp's) genes required for  virus replication, 
transcription and translation occupy 75% of the genome at the 5’ end (Allende et al., 1999). The 
remainder of the genome at the 3’ end encodes all the structural proteins of the virus. The entire 
Nsp region is encoded by 2 ORFs, ORF 1a and 1b, that together code for two large replication 
associated polyproteins pp1a and pp1ab (Ziebuhr et al., 2000). These two polyproteins are 
translated directly from the genomic RNA. Translation of pp1ab occurs by a -1 ribosomal frame 
shift signal carried in the overlapping ORF1a/ORF1b region (den Boon et al., 1991). A recently 
discovered transframe ORF (TF ORF) is present in ORF 1a and is translated by a -2PRF (Fang et 
al., 2012). The length of ORF 1a is more variable compared with ORF 1b, the main reason being 
the hypervariable region in Nsp2 within ORF 1a (Wang et al., 2013). After ORF1 is translated 
from the genomic RNA strand, pp1a and pp1ab are processed into 14 distinct non-structural 
proteins by a cascade of four virally encoded proteins (Fang and Snijder, 2010). These Nsp's are 
named Nsp1 to Nsp12 where Nsp1 and Nsp7 are further cleaved into two subunits each: Nsp1α, 
Nsp1β, Nsp7α and Nsp7β. The four proteinases that carry out the entire polyprotein processing 
are three papain-like proteases, PLPs encoded by Nsp1α, Nsp1β (den Boon et al., 1995), Nsp2 
(Han et al., 2009) and one chymotrypsin-like serine protease, SP encoded by Nsp4 (Tian et al., 
2009). ORFs 3 to 8 encode rest of the replicative enzymes which include the two key enzymes: 
RNA-dependent RNA polymerase (RdRp) encoded by Nsp9 and RNA helicase (Hel) encoded by 
Nsp10. These key enzymes then participate in the formation of specialized intracellular 
5 
 
compartments called ‘replication transcription complex’ (RTC) which are localized in the 
perinuclear region in infected cells (Pedersen et al., 1999). RTCs mediate replication of the virus 
genome as well as the generation of mRNAs.  
 
PRRSV follows the elegant and complex mRNA synthesis process which is a hallmark 
for the order Nidovirales. This involves the synthesis of a nested set of subgenomic mRNAs (sg-
mRNAs) that are translated into eight known structural proteins (Vries et al., 1990). The 3’ end 
of the genome is transcribed into a set of sg-mRNAs by the process of discontinuous minus-
strand synthesis (Pasternak et al., 2006). This mechanism is similar to copy-choice model for 
RNA recombination (Lai, 1992). These subgenomes are functionally monocistronic except for 
ORF2 and ORF5, each of which give rise to ‘a’ and ‘b’ subunits (Firth et al., 2011; Snijder et al., 
1999). Each of these subgenome length mRNAs have a common ‘leader’ sequence at the 5’ end 
which is 156-211 nt in length and the 3’ ends of sg-mRNAs are co-terminal. There is a sequence 
signal called the ‘transcription regulatory sequence’ (TRS) present at 5’ end of each ORF which 
is complementary to the TRS at the 3’ of the common leader sequence (Marle et al., 1999). 
During negative strand synthesis the transcription machinery pauses after the synthesis of ‘body 
TRS’, dissociates and binds to ‘leader TRS’ and completes mRNA synthesis. This mechanism 
results in generation of negative-sense sg-mRNAs that serve as templates for positive-sense sg-
mRNA synthesis. This process of transcription is very sensitive to mutations in Nsp1 and Nsp10 
(Tijms et al., 2001; van Dinten et al., 1997). Each of these positive-sense sg-mRNAs is used for 
translation to generate the virus structural proteins. At present the known structural proteins 
belong to two groups: glycosylated proteins (GP2a, GP3, GP4, GP5) and non-glycosylated 
proteins (2b, 5a, M encoded by ORF6, N encoded by ORF7).  N protein makes up the 
nucleocapsid layer by itself, GP5 and M are the major envelope proteins, and the rest of the SPs 
are called minor envelope proteins (Dokland, 2010).  
 
 N protein 
The length of nucleocapsid protein in EU strains is 128aa while it is 123aa long in NA 
strains (369-384 nucleotides in length)  (Mardassi et al., 1995; Meulenberg et al., 1995). This is a 
highly basic protein that weighs between 12-15 KDa. They are rich in phosphoserine residues 
and the N-terminal of the protein is positively charged which might be the RNA binding domain 
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(Wootton et al., 2002). The nucleocapsid forms homodimers and encapsidates the ssRNA 
genome.  Symmetry of the capsid was thought to be isometric but recently it is suggested to be 
pleomorphic (Spilman et al., 2009). Being the 3’ most protein to be synthesized it is the most 
abundant protein, forming 20-40 % of the total protein of the virus. Due to this and the highly 
conserved nucleotide sequence of ORF 7 the N protein is the most commonly used target protein 
in diagnosis (Dea et al., 1996; J. J. Meulenberg et al., 1998). Electron microscopic image of the 
virion shows a roughly spherical and smooth envelope with a diameter of 50-60 nm. The buoyant 
density of N protein in sucrose was found to be 1.13 to 1.178 g/cm
3 
(Mardassi et al., 1994).There 
are reports showing the localization of this protein in the nucleolus of infected cells (R.Rowland 
et al., 1999; Rowland and Yoo, 2003).  
 
 GP5 and M proteins 
These two proteins form heterodimers that are held together by disulfide bonds made in 
the endoplasmic reticulum (Snijder et al., 2003; Vries et al., 1995). GP5 is 24-26 KDa and M 
protein is 18-19 KDa in size (Mardassi et al., 1996). GP5 has a localization signal at the N 
terminal end which is cleaved off during transport from the ER to cell membrane. ORF5 has the 
most variable nucleotide sequence in the PRRSV genome and its complexity is further increased 
by the presence of multiple glycosylation sites (Meng et al., 1995; Murtaugh et al., 1995). Most 
neutralizing antibodies are targeted to epitopes in GP5 protein (Weiland et al., 2000). The role of 
glycosylation of GP5 and minor envelop proteins in the viral pathogenesis is discussed in detail 
in section 1.B.i. This protein has an apoptotic effect on PAMs and MARC-145 cells (Suárez et 
al., 1996). The M protein is non-glycosylated with three hydrophobic domains that may act as 
transmembrane regions (Faaberg and Plagemann, 1995). M protein plays an important role in 
virus assembly and budding from cells. The GP5-M heterodimer has been studied for its critical 
role in binding to cellular receptors in the process of attachment and entry of the virus (Jiang et 
al., 2007; Xia et al., 2009). 
 
 GP2a, GP3, GP4, 2b, 5a proteins 
These are the five minor structural proteins present on PRRSV envelope (Wieringa et al., 
2004). None of these proteins are required for virus replication but all of them except 5a are 
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essential for virus infectivity (Molenkamp et al., 2000b; Wissink et al., 2005). GP2a and GP4 are 
Class 1 integral membrane proteins (Snijder et al., 1999). GP2a carries disulfide resides on its 
ectodomain that are crucial for forming heterodimers with GP3 and GP4 (Wieringa et al., 2003).  
GP3 is the most heavily glycosylated envelope protein (de Lima et al., 2009). It has an N-
terminal signal sequence and a C-terminal hydrophobic domain. GP4 is a 20-35 KDa envelope 
protein that generates the most neutralizing antibodies after GP5 (Meulenberg et al., 1997). GP4 
has been suggested to interact with GP2 and GP5. This protein binds to the cell receptor CD163 
which is important for the virus attachment and internalization process (Das et al., 2010). Protein 
2b is a non-glycosylated myristolated membrane protein that has ion channel-like properties (Wu 
et al., 2001). This protein is mostly embedded in the membrane. Protein 5a is a recently 
discovered structural protein in PRRSV (Firth et al., 2011). It is hydrophobic in nature and is 
produced in low levels in cells. The viral envelope proteins are retained in the golgi-complex. 
RNA-coated nucelocapsids are wrapped in membranes of the ER or golgi complex where 
extensive processing occurs (Wieringa et al., 2004; Wood et al., 1970). Enveloped viruses bud 
from here into secretory vesicles which carry them to the plasma membrane to be released 
outside the cell. 
 
 1.A.ii. PRRS virus: genetic diversity 
 
Positive-sense ssRNA viruses encompass the group of RNA viruses with the largest 
diversity in size (3 to 32 Kb) and replicative mechanisms (Fauquet and International Committee 
on Taxonomy of Viruses., 2005). The remarkable diversity of RNA viruses is attributed to two 
features of these viruses:   
 
(1) The RNA-dependent RNA polymerase (RdRp) lacks proofreading mechanism 
(Steinhauer et al., 1992) 
(2) Large population size of the progeny (Eigen and Schuster, 1977) 
 
The knowledge about PRRSV genetic diversity has been expanding with introduction of 
new molecular sequence data which is added to the PRRSV database through several research 
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efforts globally. Lelystad and VR-2332 are prototype strains that were first isolated in Europe 
and North America respectively (Benfield et al., 1992; Meulenberg et al., 1993). Markedly these 
two strains that were found to cause similar clinical symptoms in pig herds had only 60% 
similarity at the nucleotide level (Nelsen et al., 1999). They were designated as European 
genotype 1 and North American genotype 2 strains and since then have rapidly spread globally 
and diversified genetically (Zimmerman et al., 2006).  Further nucleotide divergence up to 20% 
has been reported within each genotype (Han et al., 2007; Meng, 2000a). GP5 is the most 
variable structural region while NSP2 is the most variable non-structural region (Murtaugh et al., 
1995; Wang et al., 2013).  European isolates were classified on the basis of ORF 5 nucleotide 
sequence into 3 subtypes: Subtype I, II and III (Shi et al., 2010a). Subtype I comprised Western 
European strain and was further separated in to 12 clades.  Subtype II and III comprised Eastern 
European strains that showed greater diversity compared to Subtype I. The diversity in these 
isolates was attributed to new strain introductions in to herds, massive trade within Europe, local 
strain diversification by point mutations and recombination. Type I strain has been introduced 
into the non-European countries; USA, China, Thailand, Canada and South Korea through 
vaccinated breeders or modified live vaccines (MLVs are attenuated strains of the virus that 
elicits an effective immune response without causing clinical disease) (Chae and Choi, 2010; 
Dewey et al., 2000; Fang et al., 2007a, p. 200; Thanawongnuwech et al., 2004).  In both 
genotypes, MLV vaccine strains have contributed to the diversity. North American genotype 
viruses were classified initially using the method, restriction fragment length polymorphism 
(RFLP) (Wesley et al., 1998). However, this method has an important limitation of reliability and 
hence nucleotide sequencing is the more widely used method. The most recent comprehensive 
presentation of Type II viruses classified this genotype in to 9 lineages based on ORF 5 
nucleotide sequence (Shi et al., 2010b).  
 
The first outbreak referred to as ‘original outbreak’ occurred in late 1980s where the 
prototype strain was isolated (Collins et al., 1992). Between 1989 and early 1990s this disease 
spread to a significant number of states in the US. The second epidemic broke out in Iowa in 
1996 which was called ‘acute PRRS’ (Eric J Bush et al., 1999). The clinical characterization of 
this disease was high rate of sow mortality and abortions. This was a peculiar outbreak as the 
affected herds were vaccinated. Heterogenic sequences were isolated implying multiple 
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simultaneous outbreaks. The next outbreak occurred in 2001 in Minnesota and Canada (Han et 
al., 2006).  The causative strain of virus was designated ‘MN184’ due to its RFLP pattern and 
had unique discontinuous deletions in Nsp2 region. This epidemic was followed by the first 
emergence in summer 2006 of highly pathogenic Chinese PRRSV ‘HP-PRRS’ (Tian et al., 
2007). This outbreak caused high fever, increased mortality in adult pigs and red body 
coloration. The causative strain showed a new 30 amino acid deletion in nsp2 but this was found 
to be not the cause for its virulence. After the epidemic died out there was re-emergence of 
highly pathogenic PRRS in 2009 in China and other Southeast Asian countries (Zhou et al., 
2011). The crucial role that genetic divergence of PRRSV plays in the pathogenic mechanism of 
this virus is described in section 1.B.ii. 
 
 Origin of PRRSV 
 
There are two hypotheses for the theory of origin of distinct type I and type II PRRSV 
genotypes. Both theories propose that the two genotypes existed in circulation many years prior 
to the first outbreak, the time of divergence is disputed to be either early or more recent 
(Forsberg, 2005; Hanada et al., 2005). At present there is no evidence-based theory of emergence 
of PRRS but there is one potential hypothesis. According to this hypothesis the ancestral virus 
for PRRSV was a rodent carried virus, as Lactate dehydrogenase elevating virus (LDV) is the 
closest related Arterivirus member (Plagemann, 2003). This virus was transferred to wild boars 
in Europe which served as an intermediate host and carried it to US. Oldest records of transport 
of wild boars from Europe to North Carolina, US were in 1912. After this first possible 
introduction the virus entered domestic pig populations and evolved separately on the two 
continents until the initial outbreak. However, this theory leaves many unanswered questions 
such as the cause for a species jump and lack of larger divergence of PRRSV in wild boars.  
 
 1.A.iii. Reverse genetics and use of infectious clones 
 
Classical or forward genetics are procedures that investigate the genetic basis of an 
observed phenotype while reverse genetics is an approach where mutations are introduced in to 
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genetic sequences and the resulting phenotype is observed (Lewin, 2000). Introduction of these 
mutations may be specific or random. Procedures used for specific/site-directed mutations are 
gene silencing and homologous recombination, while chemical and transposon-mediated 
mutagenesis result in random mutations. Genetic manipulation of viruses using reverse genetics 
has become an invaluable tool for study of virus biology and development of viral vaccines. 
Genetic engineering is performed via homologous recombination with helper virus for larger 
viruses while ‘infectious clones’ are constructed for smaller sized viruses. Infectious clones can 
be defined as a full-length double stranded DNA copy of the viral genome which is carried by 
bacterial plasmids and generates a functional virus. Infectious clones for DNA viruses including 
polyomaviruses, papillomaviruses, and adenoviruses have been generated. However, this 
approach with RNA viruses has additional complications. RNA viruses have mutation 
frequencies up to 10
5
 times greater than DNA viruses (Leider et al., 1988; Steinhauer et al., 
1992). The high rate of mutation in RNA viruses creates challenges in the accurate study of 
genetic features of these viruses and this adds to the difficulty of directly manipulating RNA 
strands. All RNA viruses besides retroviruses lack a DNA phase in their life cycle and hence 
cDNA intermediates of RNA viruses are used to generate infectious clones. This approach was 
first successfully demonstrated in 1981 for poliovirus (Racaniello and Baltimore, 1981).  Since 
then infectious clones for several virus families have been reported including picornaviruses, 
caliciviruses, orthomyxoviruses, rhabdoviruses, paramyxoviruses, flaviviruses, togaviruses, 
coronaviruses, arteriviruses, and bacteriophage Qβ (Conzelmann and Meyers, 1996; Taniguchi et 
al., 1978). The exact molecular mechanism involved in generation of infectious RNA virus from 
a cDNA clone is not known. It is suggested that after transfection of cells with infectious clone, 
the bacterial plasmid enters the nucleus where the host machinery begins transcription. This 
results in generation of mRNA which in this case is full-length positive stranded viral genome. 
Bacterial plasmid sequences from both termini are eliminated and an infectious RNA virus is 
produced which initiates the normal virus life cycle. 
 
Construction of infectious clones requires the knowledge of the complete sequence of 
virus. For PRRSV, several strains have been completely sequenced (Meulenberg et al., 1993; 
Nelsen et al., 1999; Susan L. Ropp et al., 2004). The first infectious clone constructed for 
PRRSV carried the complete genome of European prototype Lelystad virus in the bacterial 
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plasmid pOK12  under the bacteriophage T7 RNA polymerase promoter (J. J. M. Meulenberg et 
al., 1998). This was followed by a similar infectious clone of the North American strain VR-
2332 (Nielsen et al., 2003). For both these clones, RNA transcripts have to be generated in-vitro 
which were then used to transfect BHK-21 cells which made virus that infected PRRS 
permissive cells. Further improvement was made when infectious clone for a more virulent 
strain, P129, was built (Lee et al., 2005).  The full-length virus genome was under the control of 
human cytomegalovirus immediate early promoter in pCMVmc1 and hence was the first DNA-
launched PRRSV clone. Following this a number of additional infectious clones for PRRS virus 
have been generated and applied for investigation of PRRS virus biology and generating novel 
vaccine candidates. 
 
 1.B. Pathogenic mechanisms of PRRS virus 
 
The arteriviruses, PRRSV, LDV, SHFV, and EAV possess several novel properties 
related to viral pathogenesis, including cytopathic replication in macrophages, the capacity to 
establish a persistent infection, as well as cause severe disease. As a group, the arteriviruses 
represent the absolute extremes in mammalian pathogenesis. For example, SHFV is nearly 100% 
fatal in Asian monkeys (Snijder and Spaan, 2007). In contrast, LDV rapidly reaches levels close 
to 1010 virions per ml in the blood with no apparent clinical signs in mice. 
 
The different outcomes following PRRSV infection are a consequence of a complex set 
of interactions between the virus and the pig host. The acute phase of viremia covers 
approximately 28 days and primarily targets alveolar macrophages. The mechanistic basis for 
acute disease, such as respiratory distress is likely a consequence of the release of inflammatory 
cytokines in the lung. Following the initial clearance from the blood, viremia periodically re-
appears (Boddicker et al., 2011), with lymphoid tissues as the primary site of virus replication. 
Virus can be isolated from lymph nodes for more than 100 days after infection and virus is easily 
shed to sentinel pigs during the asymptomatic period. Replication levels gradually decay until the 
virus eventually becomes extinct (Horter et al., 2002; Rowland et al., 2003). The mechanism for 
extinction is not clear, but probably relates to the gradual disappearance of permissive cells 
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combined with only a partially effective immune response. By definition, PRRSV is not a 
‘persistent’ virus. However, since the average lifetime of a production pig is approximately 180 
days, PRRSV infection is ‘life-long’ for the vast majority of pigs. The mechanistic basis for 
persistence is dependent on a combination of factors including; (1) a complex virion structure 
that possesses a heavily glycosylated surface, (2) re-direction of the humoral response towards 
non-surface proteins, (3) antigenic and genetic drift, and (4) subversion of interferon gene 
induction. This review primarily focuses on recent advances, reported during the past ten years, 
related to understanding the processes that contribute to persistence. 
 
 1.B.i.  Humoral immune response and the role of glycan shielding   
 
An example of the humoral response to PRRSV structural and non-structural proteins 
during experimental infection is shown in Figure 1-4. Following infection, the earliest and 
strongest antibody response is against the N protein. In contrast, the antibody response against 
the major surface component, the GP5-M heterodimer, is weak and delayed. In fact, some 
animals fail to make a detectable antibody response against GP5. The neutralizing antibody 
response, which is also weak and delayed, follows a similar pattern (Yoon et al., 1994). 
Interestingly, a strong antibody response is made against non-structural proteins (Nsp's), such as 
Nsp2. Nsp2 is not a component of the virion and is found only during the infection of cells. 
Therefore, the antibody response during infection is primarily directed against viral proteins not 
associated with virus neutralization 
 
The mechanism for the weak response against GP5 is linked to the presence of several N-
linked glycosylation sites, identified by the peptide sequence N(X)S/T. After removal of the 
peptide signal sequence, the ectodomain of GP5 is only about 30 amino acids long. The 
ectodomain possesses two conserved N-glycosylation sites, located at position N44 and N51 in 
type 2 viruses and N46 and N 53 in type 1 viruses (Plagemann et al., 2002; Wissink et al., 2004). 
In addition, the distal asparagine/ serine-rich domain, located between amino acids 30 and 38, 
possesses a small region containing a variable number of potential N-glycosylation sites. 
Depending on the virus isolate, the number of N-sites on the distal end of the ectodomain ranges 
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from 0 to 3  (Dea et al., 2000; Dokland, 2010; Plagemann et al., 2002).The role of the number of 
N-sites in Arterivirus persistence was first demonstrated by changes in the number of N-
glycosylation sites in VP-3 following the infection of mice with LDV. VP-3 of LDV possesses a 
pattern of glycosylation similar to GP5 of PRRSV with conserved sites located at N45 and N52 
(Faaberg and Plagemann, 1995). The preservation of both sites correlates with resistance to 
neutralizing antibody and persistent infection. In contrast, certain naturally occurring strains of 
LDV which are neurotropic, lack the N-terminal and N45 glycosylation sites. These isolates are 
susceptible to neutralizing antibody and exhibit a low level of viremia. Sequence analysis of VP-
3 in the residual circulating viruses showed the reacquisition of both glycosylation sites 
(Plagemann, 2004). Rowland et al. (R. R. Rowland et al., 1999) followed GP5 ectodomain 
peptide sequences in pigs exposed to VR- 2332 in utero. Within a week after birth, a mutant 
virus appeared that possessed a D to N mutation in GP5 at amino acid position 34, which created 
an additional N-glycosylation site on the distal end of the ectodomain (R. R. Rowland et al., 
1999). However, the mutant virus did not show increased resistance to neutralizing antibody. 
Costers et al. (Costers et al., 2010b)studied the appearance of mutations in GP5 during the 
infection of pigs with a type 1 PRRSV. The results showed the appearance of a D to N mutation 
at position 37 of GP5, which created an additional N-glycosylation site.  
  
A specific role for glycan shielding in GP5 was demonstrated using reverse genetics of an 
infectious cDNA clone (Ansari et al., 2006). A panel of recombinant viruses was constructed 
with different combinations of mutations at N34, N44, and, N51. The results showed viruses 
without N44 were non-viable in culture, indicating a requirement of the asparagine or sugar 
residues for replication.  The elimination of the N34 and N51 glycosylation sites resulted in the 
increased sensitivity of recombinant viruses to neutralization by antibody from virus-infected 
pigs.   In addition, the infection of pigs with viruses lacking N34 and/or N51 resulted in the 
production of increased antibody with enhanced neutralization activity against both mutant and 
parent viruses. The mechanistic basis for the role of glycans is related to the protection of a 
conserved B cell epitope located between residues 37-45 (Ostrowski et al., 2002). A similar 
epitope was identified in the same location relative to N45 and N52 sites in LDV VP3 (Faaberg 
and Plagemann, 1995).  
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Using an expression plasmid containing a modified recombinant GP5, which possessed 
an additional Pan DR T-helper cell epitope (PADRE) combined with the elimination of all 
glycosylation sites at N30, N34, N35 and N51, an increased anti-GP5 humoral response was 
detected in mice immunized with the DNA plasmid (Li et al., 2009b). PRRSV-specific 
neutralizing activity in serum was also increased, including the capacity of serum to neutralize a 
broad range of PRRSV isolates. A similar approach incorporated the expression of recombinant 
GP5 by an adenovirus vector (Jiang et al., 2007). Increased PRRSV neutralizing activity was 
obtained following the infection of mice with constructs possessing deletions in N44, N44/51, 
N30/44/51, N30/33/44/51 or N30/33. 
 
However, it should be noted that the role of GP5 as the major target for neutralizing 
antibody is not accepted by all members of the scientific community. Glycan shielding may also 
play a role in the response to minor glycoproteins. Using a reverse genetics approach, virus 
neutralization of a recombinant virus lacking N51 in GP5 was further enhanced by the removal 
of the N131 glycosylation site in GP3 (Vu et al., 2011). Viruses recovered from infected pigs 
showed the restoration of both glycosylation sites.  Martínez-Lobo et al. (Martínez-Lobo et al., 
2011) placed 39 European type1 PRRS virus isolates into 4 phenotypes based on sensitivity to 
neutralization; highly sensitive, sensitive, moderately sensitive and neutralization resistant.  
There was no correlation between the patterns of glycosylation in the structural proteins with the 
neutralization phenotype.  
 
 1.B.ii. The role of genetic and antigenic drift in persistence 
 
A recent analysis of approximately 8,500 ORF5 (GP5) nucleotide sequences indicates 
that type 2 viruses can be divided into at least nine distinct groups or lineages (Shi et al., 2010a). 
The capacity of PRRSV to rapidly change is illustrated in our previous work investigating the 
emergence of European type 1 isolates in the US (Fang et al., 2007b). Type 1 isolates of 
European origin first appeared in North America around 1999 (Dewey et al., 2000; Fang et al., 
2004; Susan L Ropp et al., 2004) and designated as North American (NA) type 1 PRRSV 
isolates.  Phylogenetic analyses was performed using ORF5 and nsp2 nucleotide sequences from 
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20 type 1 isolates collected between 1999-2004 from 10 states. The NA type 1 viruses were most 
closely related to the Lelystad virus.  Fifteen of the 20 ORF5 sequences fell into one of two 
major subgroups, designated group A and group B. The two groups had sufficiently diverged to 
the extent that antibodies derived from pigs infected with a group A isolate failed to neutralize 
viruses in group B, and vice versa.  
 
An indication of the origin for the NA type 1 viruses was found in the analysis of nsp2. 
The nsp2 nucleotide sequences showed a phylogenetic topology similar to ORF5, including the 
placement of the same isolates into the same group A and B clades.  Furthermore, 18 of the 20 
isolates possessed a single 51 nt deletion in nsp2 (Fang et al., 2004; Susan L Ropp et al., 2004).  
The deletion does not play a significant role in pathogenesis, but functions as a marker for 
tracking the origin of the type 1 isolates.  The results indicate that the high degree of genetic and 
biological diversity was derived from a single virus introduced into the U.S. 
 
Genetic diversity incorporates genetic drift through point mutations and genetic shift 
through recombination.  Estimates of the nucleotide substitution rate for PRRSV range from 4.7-
9.8X10
-2
/site/year, which is the highest rate calculated for any RNA virus to date (Hanada et al., 
2005; Jenkins et al., 2002).   Peptide sequence variability within the structural proteins is 
represented in Figure 2-5A.  The greatest peptide sequence variation is found in the ectodomain 
region of GP5, outside of the two conserved N-glycosylation sites. The conserved neutralizing 
epitope is identified by the dotted arrow.  Hypervariability is linked to the presence of decoy 
epitope located between amino acids in the region between 27 and 30. However, this epitope 
may actually lie outside of the ectodomain within the GP5 peptide signal sequence.  In type 1 
viruses, Wissink et al., (Wissink et al., 2003) identified a potential neutralizing epitope between 
amino acids 29 and 35 of GP5, which is located within a hypervariable region. Another region 
showing peptide sequence variation in the vicinity of a neutralizing epitope is found in GP4, 
where the epitope maps to amino acids 51-65 (Costers et al., 2010a, 2010b; Vanhee et al., 2010). 
Interestingly, the epitope region overlaps the open reading frame that encodes GP3. The 
arteriviruses incorporate overlapping reading frames, as means to maximize the coding capacity 
of a relatively small genome.  However, the presence of overlapping reading frames does not 
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appear to create any significant constraint on the capacity of the structural proteins to generate 
peptide sequence variability.   
 
Peptide sequence variability and hypervariability extends to the non-structural proteins. 
Examples in Figure 1-5B and C show the peptide sequences for nsp1 and nsp2. Within nsp1, the 
nsp1β polypeptide shows increased peptide sequence variation compared to nsp1α. The protease 
site marks the separation between the relatively conserved nsp1α and the variable nsp1β. 
Another example is nsp2, which possesses peptide sequence insertions and deletions combined 
with peptide sequence hypervariability. Therefore, peptide sequence variation within the Nsp’s 
appears to be important, but the mechanism of how peptide sequence variation contributes to 
fitness is not known. One possibility is that mutations in nsp1 and nsp2 may contribute to 
persistence by altering the overall level of virus replication within the cell. Another possibility is 
the requirement for physical interactions between structural and non-structural proteins during 
replication. Therefore, a change in the peptide sequence of a structural protein in response to 
immune selection may require a corresponding change in the partner Nsp in order to maintain a 
stable heterodimer.  
 
 1.B.iii. Subversion of the type 1 interferon response by non-structural proteins 
 
A number of studies have shown that pretreatment of cells with type 1interferon (IFN) 
inhibits PRRSV replication (Buddaert et al., 1998; Fang and Snijder, 2010; Overend et al., 2007).  
Therefore, the study of the escape of PRRSV from the innate immune response has primarily 
focused on the subversion of IFN gene activation. The principal observation is the down-
regulation of IFN type 1 synthesis during virus infection in cultured primary porcine 
macrophages and cell lines. After uncoating and entry of the virus genome in the cytoplasm of 
the cells, nsp1α and nsp1β are immediately translated and autocleaved from the pp1a and pp1ab 
polyprotein. This creates the opportunity to block the induction of interferon during the early 
stages of replication. A summary of observations related to the inhibition of IFNβ synthesis by 
nsp1 and other ORF1 polyprotein fragments is presented in Table 1-1.  The most common 
mechanism for the inhibition of IFNβ synthesis is the inhibition of IRF3 phosphorylation, which 
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can be mediated by nsp1, nsp2, nsp11. (Phosphorylated IRF3 is translocated to the nucleus 
where it binds to the IFNβ promoter).  However, some laboratories report no inhibition of IRF3 
phosphorylation or propose other alternative mechanisms for the inhibition of IFNβ gene 
activation. For example, Kim et al. (Kim et al., 2010) showed that nsp1 induces degradation of 
CREB-binding protein (CBP) which is a co-activator of phosphorylated IRF3 in the nucleus. An 
alternative strategy was shown by nsp2, which inhibited the polyubiquitination of IkBα 
preventing the activation of NF-kB, a transcription factor for IFN genes (Sun et al., 2010).  Luo 
et al. (Luo et al., 2008) observed that PRRSV interferes with the early steps of RIG-1 and TLR3 
pathways by blocking the activities of IPS-1 and TRIF. The differences in results may reflect 
differences in virus isolate used for infection, the cell line or perhaps, the design of the 
experiment. One intriguing possibility is that multiple viral proteins possess multiple activities in 
the inhibition of IFN synthesis.   
 
 1.B.iv. Conclusion 
 
The persistent nature of PRRSV presents significant challenges for the control and 
elimination of disease. As summarized in Fig. 1-6, subversion of the innate and humoral 
responses contributes to PRRSV persistence within a population. The strategies that PRRSV 
utilizes to neutralize host defenses have placed similar limitations on the effectiveness of the 
current modified live virus (MLV) vaccines, such as delayed and weak neutralizing antibody, 
persistent infection, and the inability to provide protection against a broad range of field isolates.  
With this new knowledge, alternative approaches are being incorporated in the design and 
development of the next generation of vaccines (Lunney et al., 2011).      
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Figure 1-1 PRRS-free regions of the world 
PRRS is globally endemic in most swine-producing countries.The red arrows show the countries 
in the world that are currently considered free of PRRSV.  
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Figure 1-2  PRRS virus genome and virion structure  
PRRS virus has a single stranded positive-sense RNA genome which is approximately 15 
kilobases in length. In the schematic representation below the proteins encoded by the genome 
are color coded in the virion.  
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Figure 1-3 PRRS virus replication, transcription and translation machinery 
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Figure 1-4 Antibody response to major structural and nonstructural proteins 
Ten pigs were experimentally infected with PRRSV and antibody measured against 
the N protein (circles), nsp2 (triangles) and the major virion surface components, 
GP5-M (squares with dotted line). Antibody was measured by ELISA and results 
shown as the mean of the sample to positive (S/P) ratio. 
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Adapted from Chand et al., 2012 
 
 
 
 
 
 
 
 
Figure 1-5 Peptide sequence variability and hypervariability in structural and 
nonstructural proteins 
Sequence variation is presented as the number of amino acid changes within a 10 amino 
acid stretch for type 2 structural proteins (A), Type 1 and type 2 nsp1 (B), and type 1 and 
type 2 nsp2 (C). Peptide sequence information was collected from GenBank. 
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Figure 1-6 Mechanism of PRRSV persistence 
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Table 1-1 Effects of PRRSV pp1ab proteins on the activation of IFNβ 
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Chapter 2 - Literature review of Recombination 
 
 2.A. General RNA recombination 
 
 2.A.i. Molecular mechanism: Copy-choice method 
 
RNA recombination was first identified in 1960s in the animal viruses Newcastle disease 
virus, poliovirus and influenza virus (HIRST, 1962; LEDINKO, 1963). Soon after, 
recombination was reported in bacteriophages, plant viruses and other animal viruses such as 
FMDV, MHV, BMV (Lai, 1992). Phylogenetic relationships showed evidence of recombination 
as a source of genetic diversity in RNA viruses (Koonin et al., 1993). Early studies of genome 
sequences, organization and amino acid similarities also suggested that recombination played a 
critical role in virus evolution (Goldbach, 1986; Strauss and Strauss, 1988). Further confirmation 
of recombination events among RNA viruses came from sequence rearrangements in natural 
strains of viruses such as: alfalfa mosaic virus, turnip crinkle virus, luteoviruses (Cascone et al., 
1990; Huisman et al., 1989; Mayo and Jolly, 1991) and identification of host sequences in 
genomes of bovine diarrhea virus (ubiquitin-coding sequence) and Sindbis virus (tRNA 
sequence) (Meyers et al., 1991; Monroe and Schlesinger, 1983). Based on the types of RNA 
molecules involved and cross-over sites, RNA recombination can be divided into 2 types: 
homologous and non-homologous recombination (Lai, 1992). Homologous recombination 
involves cross-over between two closely related RNA molecules or genetic regions as commonly 
seen in picornaviruses and coronaviruses (Jarvis and Kirkegaard, 1992; Lai et al., 1985). Non-
homologous recombination involves cross-over between distantly related RNA molecules or 
genetic regions as observed in QB bacteriophage (Munishkin et al., 1988). Homologous 
recombination usually results in conservation of the genome structure while non-homologous 
cross-over results in gene rearrangement or duplication, insertions and deletions. This property 
has been suggested to result in greater survival frequency of viruses that undergo homologous 
recombination events as compared with non-homologous recombinants.  Another layer of 
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complexity is added to the process of recombination as we frequently find both types of 
recombination occurring in viruses such as BMV (Figlerowicz and Bujarski, 1998).  
 
The established mechanism for double-stranded DNA recombination is the ‘breaking and 
joining’ method while ‘copy-choice’ has been found to be a rare occurrence in these viruses 
(Brunier et al., 1988; MESELSON and WEIGLE, 1961) . The most widely accepted mechanism 
for RNA recombination is the ‘copy-choice’ or ‘template-switch’ mechanism (Kirkegaard and 
Baltimore, 1986). The fundamental difference between these two mechanisms is that copy-
choice mechanism occurs only during RNA synthesis while breaking-joining is a non-replicative 
model. There are a few reports for evidence of non-replicative mechanisms for RNA 
recombination, mainly in Qβ replicase systems. Trans-esterification and replicase independent 
self-recombination mechanisms have been proposed(Chetverin et al., 1997; Chetverina et al., 
1999) to occur in cell-free systems. However, copy-choice mechanism is the most widely 
accepted model and has been suggested to operate for PRRS virus recombination and hence this 
model will be discussed in further details in this dissertation.  
 
 Choice-choice model 
 
 Figure 1-7 shows a schematic representation of this model. As the copy-choice model is 
a replicative mechanism it operates only during RNA synthesis and parent RNA molecules are 
not part of the newly recombined molecules. According to this model, RNA synthesis pauses due 
to a secondary RNA structure or some specific undetermined nucleotide sequence followed by a 
dissociation step. As RNA synthesis cannot be initiated independently by the nascent RNA 
strand, it was proposed that the entire transcription complex consisting of nascent RNA, 
transcription proteins and RNA polymerase dissociates from the template strand. This 
dissociated complex finds a new RNA template in the proximity and binds at a comparable site. 
Based on structural features of the nascent RNA transcript and/or the acceptor template, RNA 
binding would result in homologous or non-homologous recombination. This binding is followed 
by continuation of RNA synthesis of the RNA transcript to generate the new recombined 
molecule. In some cases nascent transcripts might be processed by endo- or exo-nucleases at the 
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3’ end before binding to new template (Banner and Lai, 1991). Such processing and imprecise 
binding lead to insertions and deletions in the progeny recombined molecule.  
 
Determination of hot-spots for recombination is the most intriguing area in the study of 
recombination. So far, a number of studies in poliovirus and FMDV have shown that sites of 
secondary RNA structures are hot-spots for recombination (Tolskaya et al., 1987; Wilson et al., 
1988) This is because they promote RNA polymerase pausing as well as act as an anchor for 
selection as a binding site. Functionality of the resulting recombined protein is a critical 
determinant for the fitness and hence survival of recombined viruses. Hypervariable regions may 
be more tolerant to structural mutation and hence this was suggested to be the reason for the 
hypervariable region in MHV spike gene to be a hot-spot (Banner et al., 1990). Further studies to 
detect hot-spots and interpretation of results must be performed with caution considering the 
influence of selection pressure on the nature of recovered recombined viruses in in-vitro 
experimental systems. This criterion was brought to attention by the different pattern of 
recombinants obtained when selection pressure was removed in a MHV-2/A59 system for 
recombination studies (Banner and Lai, 1991). The first experimental evidence for copy-choice 
mechanism was from an in-vitro system with polioviruses (Kirkegaard and Baltimore, 1986). 
This was done by co-infection of a wild-type virus (5’ guanidine sensitive, 3’ temperature 
resistant) with a double mutant (5’ guanidine resistant, 3’ temperature sensitive). Guanidine 
blocked positive- and negative-strand synthesis in wild-type virus, while non-permissive 
temperature blocked negative-strand synthesis of the double mutant. It was seen that recombined 
viruses (5’ guanidine resistant, 3’ temperature resistant) were generated under non-permissive 
temperature but were absent in the presence of guanidine.  This study showed that RNA 
synthesis of at least the donor template is required for recombination to occur and also suggested 
that cross-over occurred primarily during negative-strand synthesis.  
  
 Biological significance and mechanistic constraints of recombination  
 
Recombination is one of the mechanisms of genetic exchange that contributes to the 
diversity of RNA viruses. Biological significance of recombination has been mainly suggested in 
two areas. Firstly, recombination is considered to be an efficient process to clear RNA genomes 
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of deleterious mutations that accumulate through the high rate of mutation (Chao, 1988) and 
promote the spread of beneficial mutations (Worobey and Holmes, 1999). Secondly, 
heterologous recombination that can introduce large insertions and deletions has been suggested 
to influence genome size and organization of RNA viruses. This has been observed in members 
of the Order Nidovirales and discussed in the following section. Evidences of recombination 
resulting in beneficial purging are seen in examples such as virulent recombined viruses 
generated from attenuated vaccine strains in poliovirus (Georgescu et al., 1994) and in infectious 
bronchitis virus (Jia et al., 1995). Reports of recombination resulting in new beneficial variants 
include that of a non-cytopathogenic BVDV recombining with a host gene to generate a 
cytopathogenic recombined virus (Meyers et al., 1989). Implication of recombination on 
phylogenetic data discourages the use of portions of viral genome as accurate representations of 
the virus. This review also brings to notice the co-occurrence of re-assortment and recombination 
mechanisms in many viruses such as hantavirus (Sibold et al., 1999), influenza A virus 
(Khatchikian et al., 1989), cucomovirus (Masuta et al., 1998) and bacteriophage φ6 (Mindich et 
al., 1992). Although recombination provides significant advantages to viruses, this mechanism 
has not been found universally in all RNA viruses and also the frequency of RNA recombination 
is highly variable between viruses. The reasons for this could be a number of mechanistic 
constraints for successful recombination. A successful recombination involves occurrence of 
cross-over that results in a fitness advantage that will enable establishment and spread of the 
recombined virus. The constraints can be classified to be at 5 levels of the recombination 
process: simultaneous infection of a host, co-infection of a cell within that host, compatibility for 
co-replication, physical detachment for switching the RNA template and finally overcoming the 
selective pressures of the host (Worobey and Holmes, 1999). A successful recombined virus has 
to clear each of these 5 constraints and further be efficiently transmitted for establishment in a 
population. 
 
 2.A.ii. Recombination in Order Nidovirales 
 
PRRS virus belongs to the order Nidovirales, which includes three families: Arteriviridae 
(genus Arterivirus), Coronaviridae (genus Coronavirus and Torovirus) and Roniviridae (genus 
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Okavirus). Recently a fourth family, Mesoniviridae (genus Alphamesonivirus), has been 
proposed to be included in this order (Lauber et al., 2012). Nidoviruses have shown clear 
evidence of recombination being an important evolutionary mechanism. Many initial studies 
investigating RNA recombination were performed on coronaviruses, which showed up to a 30% 
recombination frequency over the entire genome (Lai, 1996). Toroviruses that cause enteric 
disease in cattle, horses and possibly humans were also shown to undergo frequent 
recombination (Smits et al., 2003). Little is known about Okaviruses that infect shrimp, but 
recently homologous recombination was reported in an okavirus, Yellow-head virus (YHD) 
(Wijegoonawardane et al., 2009). This is an important discovery because it is the first evidence 
of recombination in a virus infecting an invertebrate host. Arteriviruses are more extensively 
studied and there are several reports of homologous and non-homologous recombination in 
EAV, PRRSV and LDV (Li et al., 1999; Molenkamp et al., 2000a; Yuan et al., 1999a). 
Recombination has been suggested to have resulted in duplication and relocation of genes 
between different viruses in the order Nidovirales. Evidence for this was indicated in the 
presence of multiple protease (PL
pro
) proteins in corona- and arteriviruses (den Boon et al., 1995; 
Gorbalenya et al., 1991). Heterologous recombination was speculated to have resulted in 
relocation of CPD and HE genes in toro- and coronaviruses (Snijder et al., 1991). 
 
  2.A.iii. Systems to study recombination 
Systems for investigation of recombination can be classified in to two broad categories:  
(i) In vitro systems 
(ii) In silico systems 
In vitro systems are fewer in number as demonstration of recombination is a challenging 
task. However, experimental systems provide insights in to this mechanism that cannot be 
perceived through phylogenetic analysis. The popular in-vitro methods include subjecting viral 
RNA to single stranded chain polymorphism, hybridization, restriction fragment length 
polymorphism or denaturing gradient gel electrophoresis. These techniques enable detection of 
changes in binding patterns of probes and restriction sites which indicate presence of a 
recombined or new strain of virus. Isolation of viruses or amplification of virus fragments by 
RT-PCR followed by sequencing yield useful data which is analyzed using a number of different 
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software that search for recombination footprints. A multitude of programs that are being used 
for in silico recombination analysis include GARD, RDP, SimPlot, 3 SEQ, MaxChi, 
BOOTSCAN, Lard and GENECONV.  
 
Some of the experimental systems used to study recombination in viruses that infect 
plant, animal and bacteria are discussed in this section. In Brome-mosaic virus (BMV), a virus 
that infects bromegrass and barley, insertions in the UTRs that impeded virus replication was the 
system used to study recombination mechanism. Recombination in this system was detected by 
restoration of functional UTRs in progeny viruses (Alejska et al., 2005). Modification of this 
concept was used by another system where mutations were incorporated in genes encoding the 
viral RNA polymerase  (Nagy et al., 1995). The effects of these mutations were observed to be 
different for non-homologous and homologous recombination. Another BMV-based system 
involved the use of two parental viruses with different silent markers such as restriction sites, in 
the same region (Urbanowicz et al., 2005). Analyses of restriction patterns in the progeny viruses 
demonstrated different cross-over regions. Some systems in Turnip crinkle virus (TCV) and  
Cucumber necrosis virus (CNV) used a combination of genomic and satellite or defective RNAs 
respectively to determine impact of specific mutations on recombination in these viruses (White 
and Morris, 1995; Zhang et al., 1991).  This was done by co-inoculating the host with a pair of 
viruses where one carried a deleterious mutation and only recombination restored this mutation. 
A similar system was designed recently for Hepatitis C virus (Scheel et al., 2013). Co-
transfection of hepatoma cells with a replicating HCV strain that lacked envelope genes and a 
non-replicating HCV strain that carried envelope genes gave rise to viruses that had undergone 
homologous or non-homologous recombination. Introduction of cell-free systems enabled 
minimization of selection pressure and the capacity to easily modify the host environment (Kim 
and Kao, 2001; Nagy et al., 1998). These experiments demonstrated the requirement of 
secondary RNA structure in TCV and AU-rich stretches in BMV for cross-over. Transgenic 
plants that expressed viral or host factors were used to study contribution of these factors to 
recombination in infecting BMV and cucomovirus recombination RNA (Aaziz and Tepfer, 1999; 
Dzianott and Bujarski, 2004). A gene-knockout yeast system was developed to study host factors 
essential for RNA recombination of infecting viruses (Serviene et al., 2005). Classical systems 
for detection of recombination between parent viruses carrying different genetic markers such as 
47 
 
temperature sensitivity, guanidine resistance, antibody neutralization resistance and resistance to 
horse serum treatments have been used for picornavirus and coronavirus studies (HIRST, 1962; 
Pincus et al., 1986). The latest model developed to study recombination in poliovirus uses co-
infection of a wild-type and a genetically synthesized virus followed by deep sequencing of the 
resulting recombined viruses (Runckel et al., 2013). The synthetic genome carried 368 
synonymous mutations and enabled demonstration of predictive nature of recombination 
hotspots. A single cycle tissue culture assay was developed for HIV-1 recombination where the 
Env protein gene was inserted in plasmids with either a LacZ’ gene or a truncated MalT gene 
preceding the Env gene (Simon-Loriere et al., 2009). Recombinants were identified by a 
presence of a specific restriction site and functional LacZ’ gene when cloned in to bacterial cells. 
Experimental systems for PRRS virus recombination studies have not been explored greatly so 
far. The only available system is a simplistic model that involves co-infection of PRRSV 
permissive cells with different strains of the virus followed by PCR amplification using 
differential primers. The nature and shortcomings of these studies will be expanded further in the 
following section. 
 
 2.B. PRRS virus recombination 
 
 2.B.i. Previous studies 
 
Genetic diversity in PRRSV is largely the result of point mutations and recombination 
(Chang et al., 2002; Dee et al., 2001). Phylogenetic analyses provided the first evidence for 
recombination in PRRSV. In 1996, Kapur et al. reported on the phylogenetic analysis of ORFs 2 
through 7 in 10 NA isolates (Kapur et al., 1996a). There was evidence of intragenic 
recombination in all the structural ORFs except ORF6 which may be due to negative selection of 
recombinant forms in this region. In another study, 50 US field isolates were sequenced and one 
natural recombinant isolate, 93-15416, was found (Yuan et al., 1999a,). Cross-over between the 
two parent-isolates occurred within a 31 bp identical stretch in the ORF 5 region. Phylogenetic 
incongruity in a group of European isolates followed by SimPlot analysis identified an Italian 
isolate that had undergone cross-over in the end of ORF6 region (Forsberg et al., 2002a).  
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Similarly, cross-over was found to occur in nsp2/3 junction region in a NA type 1 isolate (Fang 
et al., 2007a). More recently, recombination was suggested to contribute to the genetic diversity 
of PRRSV in the British isolates where double cross-over was found to occur at the 5’ and 3’ 
ends of ORF 5 (Frossard et al., 2013). Recombination can be demonstrated in the laboratory after 
the co-infection of two different isolates. Yuan et. al. reported the co-infection of MA-104 cells 
and porcine alveolar macrophages (PAMs) with two attenuated PRRSV vaccine strains (Yuan et 
al., 1999a). RespPRRS and Prime Pac strains showed 92% sequence homology in the 1182 bp 
region analyzed that comprised part of ORF 3 through ORF 5. Recombinants were detected by 
PCR using isolate-specific primers followed by sequencing. Recombination frequency was 
estimated at 2-10 % by analysis of band density.  Real time RT-PCR approach was used to study 
inter- and intragenotype recombination in Danish and North American PRRSV isolates (van 
Vugt et al., 2001).  Intra-type recombination of viruses with 94% homology in ORF5 was 
detected at a frequency of 0.1 to 2.5% while recombination was not detected between type I and 
type II isolates (60% homology).  Cross-over regions between type II viruses possessed identical 
stretches in the range of 5-104 bases in length.  A Chinese isolate EM2007 was found to be a 
recombined virus between field and vaccine strains that had crossed over in the Nsp2 and Nsp9 
regions (Li et al., 2009a).  An in-vivo study model that isolated recombined viruses by plaque 
assay found a variety of complex cross-over patterns, especially within Nsp2 region (Liu et al., 
2011).  
 
 2.B.ii. Implications about PRRSV recombination 
 
Results from previous work have given a few insights into PRRSV recombination. 
Recombination was demonstrated to occur among European, North American and Asian isolates. 
This showed that the mechanism was not exclusive to a specific genotype or geographic region 
but rather occurred frequently.  Intra-genotype recombination frequency was found to be in the 
range of 0.1 to 10% while inter-genotype recombination was not detected. In-vitro studies using 
isolate-specific PCR demonstrated that flanking region homology promotes cross-over. 
Imprecise cross-over resulting in deletions was detected, which suggested the presence of non-
homologous recombination. Two characteristics regarding sequence homology that influenced 
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recombination were: length of identical stretches within a region and overall homology of a 
region. Length of identical stretches over which cross-over occurred was in the range of 5 to 104 
bp. Minimum overall homology required for recombination in PRRSV was found to be 89% 
which was over a 603 bp region in ORF 5. Long regions of high degree of identity that flank 
short homologous regions were suggested to promote recombination. 
 
 2.B.iii. Limitations of these studies 
 
PCR based detection of recombined viruses is the only in-vitro system to study PRRSV 
recombination available at present. In this system two parent viruses are used to co-infect 
PRRSV permissive cells. After 72 hours of infection the supernatant or cell lysate was used for 
viral RNA isolation. Isolate specific primers were used for RT-PCR amplification of a specific 
region of the virus where recombination is expected to occur.  Alteration of number of PCR 
cycles, plaque assay and real-time RT-PCR were techniques used to determine the frequency of 
recombination in these studies. Although PCR based experiments provide some insight in to the 
mechanism there are a number of limitations to this technique. The most important limitation is 
that the source of PCR template in the serum or cell culture sample cannot be restricted to 
functional virus genomes. Hence, sg-mRNA, genomic or defective RNA could serve as template 
for PCR for the region under analysis. Therefore, viability of the recombined virus carrying the 
detected recombination event is not known. Secondly, sequencing of PCR products has shown 
the occurrence of complex pattern of cross-overs. As PCR primers are targeted to a specific 
region of the genome all cross-overs occurring outside the targeted region are neglected. 
Therefore this system would underestimate the recombination frequency of the virus. Thirdly, as 
only RNA sequence is detected and not the entire virion, the impact of the recombination event 
on the phenotype of the virus is unknown. Furthermore, random mutations in primer attachment 
regions might result in false-negative results for PCR and hence be unable to detect recombined 
viruses in the sample. 
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 2.B.iv.  Significance of the study of PRRSV recombination 
 
Features of PRRSV that make it a good candidate for recombination are as follows: 
 
(i) Discontinuous replication mechanism involves an inherent pausing and detachment step 
of the RNA polymerase machinery which is a crucial factor for recombination to occur 
(Snijder and Meulenberg, 1998). 
(ii) PRRSV has been shown to propagate as a ‘quasispecies’ starting from a single strain 
infecting an animal (R. R. Rowland et al., 1999). This creates opportunity for intra-strain 
recombination and thus circumventing the need for dual infection. 
(iii) One of the main challenges with elimination of PRRS is the persistent nature of the virus 
(Chand et al., 2012). This results in prolonged periods of association of virus in the 
animal and hence increases the possibility of co-infection of cells. 
 
Implications of recombination are expected in two broad areas within PRRSV research:  
 
Diagnostics and vaccination: Recombination directly impacts genetic diversity and 
hence there would be an important implication of recombination on vaccination and diagnostic 
strategies (Forsberg et al., 2002a; Meng, 2000a). Detection of emergence of a recombined isolate 
between a vaccine and a field strain in China proposed the question: Are live vaccines capable to 
shape evolution of PRRSV through recombination? (Li et al., 2009a). Isolation of viable 
recombined viruses resulting from cross-over events between vaccine and field strain have been 
detected in a number of studies from Britain and China (Frossard et al., 2013; Li et al., 2009a; 
Wenhui et al., 2012). MLV vaccine is used extensively in for the control of this disease and 
hence the potential for recombination with field strains is a significant concern.  
 
Epidemiology and evolution: Tracing recombination events during the evolution of a 
virus is a challenging task (Wiuf et al., 2001). Knowing the contribution of recombination could 
help explain some of the genetic divergence observed over time and geographical locations. A 
study that detected a recombination event among NA type 1 viruses pointed out that 
recombination events are important in epidemiological studies of this PRRSV genotype (Fang et 
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al., 2007a). Recombination causes construction of phylogenetic trees to stagger (Pond et al., 
2012). Cross-over has most often been detected in ORF 5 and this is the region most commonly 
used for classification and genotyping. Therefore, regular screening of sequence databases for 
recombination is required. A study that identified two recombined HP-PRRS viruses made an 
interesting observation regarding their pathogenicities (Chen et al., 2013). Two highly 
pathogenic parent strains generated a highly pathogenic recombined virus, while when high and 
low pathogenic strains recombined, a low pathogenic virus was generated. This suggested the 
possibility of recombination events generating highly pathogenic viruses. In recombination 
studies for PRRSV recombination has been detected throughout the genomic region and no 
defined hotspots have been confirmed. 
 
Recombination could also be the source of emergence and re-emergence of unique and 
highly pathogenic strains that cause outbreaks. These include the following outbreaks: acute 
PRRS in the Midwest in 1996, HP-PRRS in China in 2006 and 2009, and isolation of East 
European sub-type3 strain named ‘Lena’  (Karniychuk et al., 2010; Mengeling et al., 1998; Tian 
et al., 2007). In a commentary regarding PRRSV recombination it was suggested that 
consequence of recombination in PRRSV would depend on the nature of the parental strains: 
recombination between attenuated strains, between virulent strains and between attenuated and 
virulent strains (Mengeling WL., 2002). In each of these cases the possibility of the occurrence 
of recombination and survival of the recombined virus may be different. If two virulent strains 
co-infect a pig, their replication rates would be comparable which would enable recombination to 
happen in co-infected cells in the pig. However, as every virus has a replication threshold; it 
might not be theoretically possible that the progeny would have a higher replication competency 
to outgrow its parents. However, if this occurs it would have serious adverse consequences. 
Recombination between attenuated strains might occur in case a multi-strain vaccine approach is 
applied. Emergence of a recombined strain showing higher virulence cannot be easily explained. 
However, in case the resulting recombined virus has a higher replication rate than the parents it 
might not supersede the virulence of the original field strain of the attenuated parent. Lastly, co-
infection of virulent (field strain) and attenuated (vaccine strain) strains seems to be the most 
commonly occurring situation. As the replication rate of these two strains would be considerably 
different, prolonged co-existence and hence chances of co-infection of cells within the pig appear 
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to be lower. However, reports have shown that this type of recombination events are the most 
commonly reported cases. Furthermore, in some cases the progeny has gained higher 
pathogenicity than the parents. This implies the significance of natural recombination in the field 
as well as exemplifies our limited understanding of the process. Better knowledge of 
recombination patterns would help make accurate derivations of evolutionary history of PRRSV 
and also predict strains that might emerge through recombination. Recently, there has been one 
in silico study that has associated recombination with an outbreak (Shi et al., 2013). Currently 
circulating strains since the 2009 re-emergence of HP-PRRSV in China were shown to have 
resulted from a recombination event that took place between two highly pathogenic strains from 
the 2006 outbreak. This recombination event did preserve the pathogenicity of the virus as well 
as had the fitness required to replace the parental viruses that were in circulation. Although this 
study does not provide evidence to comment about the influence of the recombination event on 
the pathogenicity of the virus, it provides support for the significance of study of recombination 
in PRRSV. Phylogenetic inconsistencies between different ORFs and rejection of molecular 
clocks are factors commonly considered indicative of recombination in PRRSV (Forsberg et al., 
2002a). 
 
Lastly, recombination studies would help answer some of the questions that are still 
unanswered about the biology of PRRSV. Factors such as increased replication rate, immune 
selection and cell receptor affinity have been suggested to give the recombined virus selective 
advantage over the parent viruses. If the recombination event in a structural gene changes the 
conformation of a neutralizing epitope then this recombined virus has the potential to escape 
immune pressure and hence survive better than the parent virus. Similarly, if the recombination 
event changes the viral protein involved in attachment to a cell receptor such that it is now 
susceptible to new tissue this feature would change the cellular tropism of the recombined virus. 
However, the role of each of these factors has not been specifically investigated. Cross-over has 
been detected in Nsp2, 7, 9 and 11 and in all the structural ORFs. However, there is no evidence 
to confirm if this is a random process or if there are specific hotspots along the PRRSV genome. 
Furthermore, viral determinants of recombination frequency have not been identified yet. At 
present there are no studies investigating how recombination is impacted by host factors such as, 
tissue microenvironment, immune pressure and timing of recombination events during the course 
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of infection. The frequency at which recombination occurs in the field may be underestimated 
due to limitations in detection techniques. It is possible that the frequency may be overestimated 
as most field reports of recombination have been identified as a single recombined virus and not 
an established strain in a herd (Forsberg et al., 2002b; Li et al., 2009a; Mu et al., 2013). This 
could be due to the fitness cost that the recombination event has on the virus.  
 
 2.B.v. Goal of the research in this dissertation 
 
The primary requirement to investigate recombination mechanism is the establishment of 
a robust in-vitro system. These limitations in the in-vitro tool combined with the knowledge gap 
in recombination in PRRSV motivated this project to develop an in-vitro experimental model. 
Specifically the overall goal of this project was to establish a model system and study 
recombination. The system was required to have the following features:  
(i) Detect viable recombined viruses in absence of selection pressure  
(ii) Easy detection method 
(iii) Conduct genetic manipulation to investigate mechanism & frequency of 
recombination 
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Figure 2-1 General mechanism for RNA recombination: Template-switch model/copy-
choice model established in 1974 
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Figure 2-2 Types of recombination: Homologous and Non-homologous 
 
 
 
 
 
 
 
 
 
 
 
 
 
62 
 
Chapter 3 - Incorporation of green fluorescent protein for the study 
of recombination in porcine reproductive and respiratory syndrome 
virus (PRRSV) 
Ranjni Chand, Yu Wang, and Raymond R. R. Rowland 
Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS 
66506, USA 
 
 Abstract 
 
A model system incorporating infectious clones that expressed green fluorescent protein 
(GFP) or destabilized red fluorescent protein (RFP) was developed to investigate recombination 
in porcine reproductive and respiratory syndrome virus (PRRSV). The co-infection of MARC-
145 and porcine alveolar macrophage (PAM) cells with RFP and GFP viruses demonstrated the 
capacity of permissive cells to be superinfected with PRRSV, a necessary first step in 
recombination.  To study recombination, a full-length PRRSV-enhanced GFP (EGFP) infectious 
cDNA clone was prepared that possessed an Arg to Cys mutation at position 97 of EGFP (EGFP-
97C), which resulted in a non-fluorescent EGFP. The P129-EGFP-97C infectious clone plasmid 
was co-transfected along with a defective infectious cDNA clone, P129-EGFP-d(2-6), which 
lacked ORFs 2 through 6, but expressed a native EGFP. The result for successful recombination 
between full-length and defective genomes was the recovery of virus that expressed a fluorescent 
EGFP.   The role of sequence homology in recombination was investigated by substituting EGFP 
with GFP, which possess 83% sequence identity. Co-transfection of EGFP and GFP failed to 
yield a fluorescent virus.  However, successful recombination was obtained after replacing a 290 
nucleotide segment in GFP with sequence identical to EGFP.  Fluorescent viruses were not 
obtained when EGFP was expressed as a separate cytoplasmic mRNA, suggesting a requirement 
of the viral replication complex for efficient recombination.   
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 3.A.  Introduction 
 
Porcine reproductive and respiratory syndrome (PRRS) incurs significant economic 
losses to the pork industry worldwide.   In the late 1980’s, PRRS appeared almost 
simultaneously in North America and Europe (Benfield et al., 1992; Collins et al., 1992; 
Wensvoort et al., 1991). Clinical signs of PRRS include respiratory disease in young pigs and 
reproductive failure in pregnant sows (Hopper et al., 1992; Pejsak et al., 1997). The disease is 
endemic in all major pork-producing countries, with only the Australian continent free of 
disease, along with countries, such as New Zealand, Norway, Chile, Sweden and Switzerland 
(Canon et al., 1998; Cho and Dee, 2006). The etiological agent is an enveloped single-stranded, 
positive-sense RNA virus, PRRS virus (PRRSV), which belongs to the family Arteriviridae in 
the order Nidovirales (Cavanagh, 1997; Meulenberg, 2000; Snijder and Meulenberg, 1998). 
PRRSV isolates are further divided into two distinct genotypes; European (EU) type 1 and North 
American (NA) type 2 strains (Allende et al., 1999; Nelsen et al., 1999). In 1999, European-like 
type 1 viruses were identified in North America and designated as NA type 1  (Fang et al., 
2007a; Susan L. Ropp et al., 2004). The PRRSV genome is approximately 15 kb in length and 
contains at least ten open reading frames (ORFs) (Dokland, 2010; Johnson et al., 2011b). Virus 
replication incorporates the production of a nested set of subgenomic mRNAs, which possess a 
common leader and poly-A tail. After entry and uncoating, ORFs 1a and 1b are directly 
translated into pp1a and pp1ab proteins, which are proteolytically cleaved into 14 non-structural 
proteins.  Located on the 3’ end of the genome are ORFs 2, 3, 4 and 5, which code for 
glycosylated envelope proteins, GP2a, GP3, GP4, and GP5. ORFs 2b, 5a and 6 code for the non-
glycosylated envelope proteins namely: 2b, ORF5a protein and M, respectively. ORF 7 codes for 
the nucleocapsid (N) protein.  
 
     PRRSV is considered one of the most genetically diverse animal viruses with an 
estimated mutation  rate of 10
-2
/site/year (Hanada et al., 2005; Jenkins et al., 2002).   One 
outcome is the divergence of type 1 and type II viruses, which possess about 60% identity at the 
nucleotide level (Nelson et al., 1993). The analysis of ORF5 sequences shows that strains within 
each genotype can possess up to 20% variability (Han et al., 2007; Meng, 2000b). The 
consequences of genetic diversity are vaccine failure in the field, as well as the emergence of 
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novel viruses with increased virulence. In general, vaccines provide the best protection against 
viruses similar to the vaccine strain with cross-protection dropping off as peptide sequence 
diverges from the vaccine strain (Labarque et al., 2004; Meng, 2000b; Murtaugh et al., 2002). 
 
    The first step in recombination is the superinfection of cells with two or more viruses. 
Once inside the cell, recombination occurs during the synthesis of genomic RNA or subgenomic 
mRNA replication. Recombination  occurs through a template switch or ‘copy-choice’ 
mechanism, first described for polioviruses (Cooper et al., 1974). Three prerequisites for 
template switching to occur are: 1) RNA replication machinery must dissociate from the parent 
template; 2) the acceptor template must occur in the vicinity of the replication complex, and 3) 
the acceptor template must promote landing of the replication complex and resume RNA 
synthesis. Secondary RNA structures and sequence homology between donor and acceptor 
templates are factors that influence selection of a recombination site. Recombination in 
coronaviruses has been extensively studied in murine hepatitis virus (MHV) using temperature 
sensitive mutants (Lai et al., 1985). Coronavirus possess a recombination frequency of about 
25% across the entire genome (Lai, 1996). Recombination has been found to occur between viral 
genome and defective-interfering RNAs or plasmid derived mRNAs. These properties have been 
used as a tool to manipulate the coronavirus genome (Masters et al., 1994). 
 
     Based on the analysis of sequences from field viruses, Kapur et al reported the first 
evidence for recombination within the structural genes of PRRSV (Kapur et al., 1996b). In a later 
study, 50 US field isolates were sequenced and one natural recombinant virus was identified, the 
result of a cross-over within a 31bp region of ORF 5 (Yuan et al., 1999b). Phylogenetic 
incongruity in a group of EU isolates identified an Italian isolate that had undergone a 
recombination event in ORF6  (Forsberg et al., 2002a).  Similarly, Fang et al. identified a 
recombined NA type 1 isolate that possessed a crossover site in the nsp2/3 junction region (Fang 
et al., 2007a).  
 
    Recombination between PRRSV isolates has also been demonstrated in the laboratory. 
Cells are co-infected with two isolates followed by differential PCR, using combinations of 
isolate-specific primers (van Vugt et al., 2001; Yuan et al., 1999b). This experimental approach 
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has demonstrated several properties associated with recombination. First, recombination 
frequencies can be as high as 10% when cells are infected with two closely related isolates (Yuan 
et al., 1999b).  Secondly, the frequency of recombination is inversely related to the degree of 
sequence homology between the two viruses; as nucleotide sequence homology diverges, the 
frequency of recombination decreases to the extent that recombination between type 1 and type 
II viruses becomes an uncommon event (van Vugt et al., 2001). And finally, imprecise 
recombination can yield insertions and deletions at crossover sites.  
 
       In this study, a model system for investigating recombination has been described. 
This model incorporates reverse genetics and infectious PRRSV clones that express a fluorescent 
protein gene as a separate subgenomic mRNA. Successful recombination is easily identified by 
gain of biological function; i.e. fluorescence. This approach can be used to investigate the 
properties of recombination in a virally expressed gene that is non-essential for virus replication.  
  
 3.B. Materials and Methods 
 
 3.B.i. Cells and infectious clones 
 
All procedures were performed after approval by the Kansas State University institutional 
biosafety and animal use care committees. MARC-145 cells and HEK-293T cells were 
propagated and maintained in Eagle’s Minimum Essential Medium (Sigma-Aldrich, St. Louis, 
USA) with 7% fetal bovine serum (Sigma-Aldrich, St. Louis, USA) and supplemented with 
0.01% pen/strep and 0.008% Fungizone. Porcine alveolar macrophage (PAM) cells were 
collected from 3 to 4 week old piglets by lung lavage in sterile 1 X phosphate buffered saline 
(PBS). PAMs were maintained in 1 X RPMI (Gibco-Life Technologies, Grand Island, USA) 
supplemented with 10% FBS, 0.01% pen/strep, 0.008% Fungizone and 1% L-glutamine (Life 
Technologies, Grand Island, USA). Cells were maintained at 37ᴼC with 5% CO2.  Full-length  
and defective viruses were derived from the DNA-launched P129-GFP infectious clone (Welch 
et al., 2004). The parent infectious clone was derived from a North American PRRSV strain, 
P129 (GenBank Accession #AF494042).  The original P129 clone was further modified to 
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express GFP from an independent sub-genomic mRNA inserted between ORF1 and ORF2 (Pei 
et al., 2009).  Modifications of the P129-GFP clone used in these experiments are diagrammed in 
Figure 1A. The EGFP-97C and DsRed genes were inserted between AflII and MluI restriction 
sites present in the original infectious clone P129-GFP (Pei et al., 2009). With reference to P129-
GFP, AflII is at position 12057 and MluI is at 12785. These 2 restriction sites were inserted 
between ORF1b and ORF2 after nucleotide number 12056. P129-RFP was constructed by 
replacing GFP with DsRed obtained from pDsRed-N1 (courtesy of Yongming Sang). P129-
EGFP-97C was constructed by replacing GFP with a mutated EGFP gene that possessed a single 
nucleotide, C to T, change at nucleotide position 289, which resulted in an arginine to cysteine 
change at amino acid 97 in the native EGFP gene (derived from pEGFP-N1, Clontech, Mountain 
View, USA) (GenBank Accession #U55762). The defective replicating virus, P129-GFP-d(2-6), 
was constructed by deleting the structural genes, ORFs 2-6, in the parent P129-GFP plasmid. 
This was accomplished in two steps; first, a MluI site was placed in front of the subgenomic 
transcription-regulating sequence (TRS) located in front of ORF7. A second MluI site was 
already present at the 3’ end of GFP. The intervening ORFs 2-6 were removed by MluI digestion 
followed by re-ligation.  The remaining defective viruses, P129-EGFP-d(2-6) and P129-GFPm-
d(2-6),  were constructed by replacing the GFP gene in P129-GFP-d(2-6) with the native EGFP 
gene and GFPm (Figure 1B). Existing AflII and MluI restriction sites were used for cloning 
GFP, EGFP and GFPm genes into the P129 genome (Pei et al., 2009).  The GFPm gene, which 
possessed a 290 bp stretch of identity between GFP and EGFP (see Figure 1B), was prepared by 
commercial gene synthesis (GenScript, Piscataway, USA).  
 
 3.B.ii. Transfection of HEK 293T cells and infection of MARC-145 cells 
 
Viruses were derived by first transfecting HEK cells with infectious clone plasmid DNA 
followed by incubation for 48 hours at 37 ᴼC and 5% CO2. Transfection of HEK cells on 24-well 
plates was performed with 0.54 μg plasmid DNA using Fugene HD transfection reagent 
(Promega, Madison, USA) according to manufacturer’s recommendations. Successful replication 
was confirmed by presence of fluorescence and/or positive staining for the expression of 
nucleocapsid (N) protein. For N protein staining, cells were washed two times with PBS and then 
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fixed with 4% paraformaldehyde for 30 min. The fixed cells were then permeabilized with 
0.02% saponin and then stained with mAb SDOW-17 at a 1:1000 dilution in PBS with 10% goat 
serum (PBS-GS). After 30 minutes, the cells were washed with PBS. SDOW was detected using 
a 1:500 dilution of secondary antibody goat anti-mouse IgG conjugated with Alexa fluor 594 nm 
(Invitrogen-Life Technologies, Grand Island, USA). After one hour incubation at room 
temperature, the cells were washed with PBS and visualized under a fluorescence microscope. 
 
       For preparation of virus stocks, infectious clone-transfected HEK cells were freeze-
thawed and media centrifuged to remove cell debris, and the virus stored at -80ᴼC until further 
use. Viruses were further propagated in MARC-145 cells. Three days after infection of confluent 
MARC-145 cells, the presence of infection was confirmed by green fluorescence and/or the 
presence of cytopathic effect (CPE). Viruses were further amplified by passage on MARC-145 
cells. 
 
 3.B.iii. Flow cytometry and fluorescence microscopy 
 
Flow cytometry was performed at 48 hours after infection or transfection, when 
fluorescence was clearly visible under the fluorescence microscope. Plates were washed with 
PBS and cells were removed after adding a few drops of 0.25% Trypsin-EDTA (Gibco-Life 
Technologies, Grand Island, USA). Cells were resuspended in PBS with 1% paraformaldehyde 
and analyzed using a FACS Calibur flow cytometer (Becton Dickinson, Franklin Lakes, USA). 
Data were analyzed using BD CellQuest Pro software. For confocal microscopy, MARC-145 
cells were cultured in 35 mm glass bottom microwell dishes (MatTek, Ashland, USA) with 500 
μl of medium. At 48 hours after infection/transfection, cells were imaged by a confocal 
microscope (Nikon Eclipse TE 2000-E, Melville, USA) with a Quantem 512 SC camera and NIS 
Elements 3.0 software was used to merge images. 
 
 3.B.iv. Preparation of EGFP-expressing HEK and MARC-145 cell lines 
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MARC-145 or HEK cells were transfected with pEGFP-N1 (Clontech, Mountain View, 
USA)). Forty-eight hours later, cells were reseeded to 50% confluency in a new flask and 500 
μg/mL G418 added. G418 is an antibiotoic that belongs to the aminoglycoside group of 
compounds similar to gentamicin. Neomycin resistance gene (Neo) carried by plasmids such as 
pEGFP-N1 confers resistance to G418. This is used as a selection system in mammalian cell 
lines. Medium was changed every 3 to 4 days to remove dead cells. Cells were maintained with 
G418 at a concentration of 200 μg/mL. 
 3.B.v. PCR amplification of EGFP/GFP and DNA sequencing 
 
MARC-145 cells, obtained at three days after infection, were enriched for viruses that 
expressed native EGFP by two rounds cell sorting that selected for cells that expressed green 
fluorescence (BioRad S3 Cell Sorter, Hercules, USA).  RNA extraction of sorted cells was 
performed according to manufacturer’s protocol using the MagMax Viral RNA Isolation Kit 
(Ambion -Life Technologies, Grand Island, USA). RT-PCR was performed using a One Step 
RT-PCR kit (Qiagen, Valencia, USA) according to manufacturer’s instructions. The forward and 
reverse primers amplified a 737 bp region between AflII and MluI restriction sites, which 
covered the entire EGFP/GFP. The sequences for the GFP-AflII forward and GFP-MluI primers 
were cttaaggccaccatgagcaagggcgaggagctgttc and acgcgtcacttgtacagctcgtc, respectively 
(restriction sites underlined). The RT-PCR amplified fragments were gel purified using the 
Wizard SV Gel and PCR Clean-Up System (Promega, Madison, USA) and cloned in the pCR 2.1 
Topo vector (Invitrogen-Life Technologies, Grand Island, USA) and sequenced (ACGT, 
Wheeling, USA). Sequences were analyzed using Mega 5.2 software.  
 
 3.C. Results 
 
 3.C.i. Co-infection of MARC-145 cells and PAMs with GFP and RFP PRRS viruses  
 
Since the first step in recombination is the superinfection of single cells, MARC-145 and 
PAM cells were evaluated for the presence of dual fluorescence after co-infection with P129-
69 
 
GFP and P129-RFP viruses. Except for the differences in the nucleotide sequence of the two 
fluorescent genes, both viruses were identical.  These viruses exhibited similar growth kinetics, 
achieving levels of between 10
7
 and 10
8
 TCID50/ml within 36 hrs after infection of MARC-145 
cells (Figure 2). The maximum number of fluorescent cells at 48 hrs after infection was achieved 
using a MOI of 10. Even at 10 MOI, only about 10% of cells were fluorescent after the first 
round of replication (data not shown).   
 
     To demonstrate that cells were capable of simultaneously expressing GFP and RFP 
proteins, HEK cells were co-transfected with P129-GFP and P129-RFP plasmids, at a ratio of 
1:1. Each plasmid was used at 0.27 μg to make up 0.54 μg total DNA for every transfection 
reaction in a 24-well plate. After 48 hours, the co-localization of green and red fluorescence was 
observed in single cells (see Figure 3A).  MARC-145 cells were co-infected with P129-GFP and 
P129-RFP viruses at a ratio of 1:1 and MOI 10 which was the total MOI of the two viruses when 
combined.  . An example of co-localization of red and green fluorescence in a single infected 
MARC-145 cell is shown in Figure 3B. PAM cells were also co-infected with red and green 
viruses.  A representative example of a PAM cell with green and red fluorescence is shown in 
Figure 3C.   Cells expressing dual fluorescence were further analyzed using flow cytometry. 
MARC-145 cells were infected with different ratios of P129-GFP and P129-RFP viruses. The 
results, presented in Figure 4, showed the cells in all four scatter plot quadrants; fluorescence 
negative cells, GFP single-positive cells, RFP single-positive cells and double-positive cells.  
Even though a total MOI of 10 was used for infection, at least 42% of cells remained negative 
for fluorescence.  The maximum percentage of double-positive cells was achieved using a ratio 
of 8:1, P129-GFP:P129-RFP. At this infection ratio, 9.6% of total cells or 17% of fluorescent 
cells were double-positive.  Together, these data demonstrate that MARC-145 cells can be easily 
superinfected and under appropriate experimental conditions, the rate of co-infection is relatively 
high.  
 
 3.C.ii. Recombination within EGFP 
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The above results demonstrated that MARC-145 cells can be co-infected with at least two 
PRRS viruses.  Recombination within EGFP was studied by constructing a non-fluorescent 
infectious virus clone that contained a single mutation in EGFP (see Figure 1). The arginine at 
amino acid position 97 of EGFP, or position 96 of GFP, is required for fluorescence. Changing a 
single C to T at nucleotide position 289 of EGFP changed the arginine to cysteine, which results 
in a corresponding loss of fluorescence (Kim et al., 2007). The model system illustrating 
recombination within mutant EGFP to yield a fluorescent protein is shown in Figure 5. 
Consistent with the template switch model, the production of a fluorescent virus can occur by 
single or multiple cross-over events. The minimum requirement for a detectable recombined 
virus in this system would be a single recombination event within the 426 nucleotide region 
located between the 97C mutation and the MluI site on the 3’ end of EGFP. After transfection of 
HEK cells with only the P129-EGFP-97C plasmid, cells were negative for green fluorescence, 
but positive for the expression of the N protein, indicating that the construct was replication 
competent (see Figure 6A). The resulting virus was capable of productively infecting MARC-
145 cells (data not shown). Infected cells remained negative for EGFP fluorescence and positive 
for N protein staining after six sequential passages of the P129-EGFP-97C virus on MARC-
145cells. This demonstrated that the 97C mutation was stable and infectious was produced 
during each passage. The second plasmid construct contained a modified P129-EGFP infectious 
clone, which contained a deletion of ORFs 2 through 6, to create the defective virus, P129-
EGFP-d(2-6). Transfection of HEK cells with the P129-EGFP-d(2-6) plasmid resulted in green 
fluorescence (see Figure 6D). The same cells stained positive for the N protein (Figure 6C); 
therefore, ORFs 2-6 did not affect the synthesis of EGFP or N protein subgenomic mRNAs. The 
media recovered from transfected cells, when placed on MARC-145 cells, did not produce green 
fluorescence or positive staining for N protein (data not shown), demonstrating that the defective 
virus, which lacked all of the surface proteins, was not capable of infecting MARC cells.   At 48 
hrs after co-transfection of HEK cells with the full-length and defective infectious clones, the 
media was transferred to MARC cells. The result was the appearance of cells that expressed the 
N protein and green fluorescence, indicating the presence of recombination between the full-
length and defective viral genomes (see Figure 6, panels E and F). The recovery of recombined 
fluorescent viruses was confirmed after a second passage on MARC cells. 
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     To estimate the frequency of recombination, media from MARC-145 cells was 
removed at 48 hrs after infection and virus titration performed. TCID50/mL values for the non-
fluorescent P129-EGFP-97C virus and recombined green fluorescent virus were 1.5 X 10
5
 and 5 
X 10
2
, respectively. Therefore, the ratio of parent and recombined viruses was approximately 
300 fluorescent negative viruses for every fluorescent virus or a recombination frequency of 
about 0.3%.  
 
        The EGFP nucleotide and peptide sequences represent modifications of the native 
GFP isolated from the jellyfish, Aequorea victoria. The EGFP peptide sequence is a single amino 
acid longer than GFP and possesses two amino acid substitutions, which result in a red shift in 
fluorescence. Furthermore, the EGFP cDNA is codon optimized for optimal expression in 
mammalian cells (Haas et al., 1996). The result is a 124 base pair difference or 83% nucleotide 
identity between GFP and EGFP. For the purpose of comparison, the overall nucleotide identity 
between Type I and Type II genotype PRRS viruses is approximately 60 to 70%. Within the 
Type II PRRSV genotype group, isolates possess homologies as low as 85% in ORF5 (personal 
observation) and 60% in nsp2 . 
 
 The nucleotide sequence differences were used to determine if recombination in the 97-
C region would occur between GFP and EGFP.   HEK cells were co-transfected with P129-GFP-
d(2-6) and P129-EGFP-97C plasmids at ratios of 1:10, 1:5, 1:2.5 and 1:1. At 48 hrs after 
transfection, media were transferred to MARC-145 cells and cells visualized for green 
fluorescence 48 hrs later.  The results, presented in Figure 7 (panels A and B), showed that the 
P129-GFP-d(2-6) construct successfully expressed the N protein and GFP fluorescence in HEK 
cells.  Viruses derived from the co-transfection of P129-GFP-d(2-6) and P129-EGFP-97C 
plasmids were able to infect MARC-145 cells productively (Figure 7C), but remained negative 
for fluorescence for all plasmid ratios (Figure 7D). These results demonstrate that P129-GFP-
d(2-6) is replication competent, but GFP and EGFP failed to recombine.  
 
      One possibility for a negative recombination result was the lack of sufficient 
nucleotide sequence homology between GFP and EGFP. To test this possibility, the experiment 
was repeated using a defective virus that expressed GFPm, a modified GFP that possessed a 
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large region of nucleotide identity with EGFP (see Figure 1B). The region of identity flanked 
both sides of the 97-C mutation.  When transfected into HEK cells, the P129-GFPm-d(2-6) 
plasmid produced green fluorescence and expressed the N protein demonstrating that the 
construct was fluorescence positive and replication competent (Figure 7C and D). Viruses 
derived from the co-transfection of the HEK cells with P129-EGFP-97C and P129-GFPm-d(2-6) 
plasmids were able to produce green fluorescence in MARC-145 cells, indicating successful 
recombination between EGFP-97C and GFPm genes.  Fluorescence-activated cell sorting was 
used to enrich for fluorescent cells. After RNA extraction, the region between the AflII and MluI 
restrictions sites on the ends of the EGFP and GFPm were amplified by PCR and cloned into 
pCR2.1 vector. Six plasmids were selected and sequenced. All cloned products showed the same 
DNA sequence, which included a single crossover site located between nucleotide position 
651and 672 (see Figure 8).  
 
 
 3.C.iii. Virus recombination with cytoplasmic mRNA 
 
This study also determined if the P129-EGFP-97C virus could recombine with EGFP 
when EGFP was expressed as a cytoplasmic mRNA. MARC-145 and HEK cell lines were 
created that stably expressed an EGFP placed under the control of a CMV promoter. EGFP-
MARC cells were infected with P129-EGFP-97C virus and media harvested 5 days later. There 
was no evidence of fluorescence. The experiment was repeated by transfecting EGFP-HEK cells 
with plasmid P129-EGFP-97C. Media were harvested 48 hrs later and then placed on MARC-
145 cells. Cells were productively infected, but failed to express fluorescence (data not shown). 
Under these experimental conditions, the results suggest that recombination does not occur when 
EGFP is expressed as separate cytoplasmic mRNA. 
 
 3.D. Discussion 
 
     In this study, the use of fluorescent protein genes, infectious cDNA clones, and 
reverse genetics as a model system to investigate the properties of recombination in PRRSV have 
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been described.  The experimental model incorporates native and mutated fluorescent protein 
genes expressed during PRRSV replication via a separate viral subgenomic mRNA fragment, 
located between ORF1b and ORF2 of the PRRSV genome.  One advantage in the use of a 
fluorescent protein expressed as a separate mRNA is that mutations and other modifications can 
be made to the fluorescent protein gene without disrupting viral genes required for virus 
replication. A second advantage is that successful recombination is easily detected by the 
acquisition of fluorescence in a replication competent virus.  
 
    Although recombination has been found to occur in a large number of RNA viruses 
this is a complex process with at least five levels mechanistic constraints. These include: 
simultaneous infection of a host, co-infection of a cell within that host, compatibility for co-
replication, physical detachment for switching the RNA template and finally overcoming the 
selective pressures of the host (Worobey and Holmes, 1999). A recombined virus has to clear 
each of these 5 constraints and further be efficiently transmitted for establishment in a 
population. Therefore, the first step in recombination which is superinfection of cells with two or 
more viruses was demonstrated to occur in the experimental system to study recombination. As 
shown in Figure 3, the co-infection with P129-GFP and P129-RFP viruses produced cells that 
contained both proteins, demonstrating that MARC-145 cells and PAM cells readily support 
superinfection. Under optimal experimental conditions, up to 17% of MARC cells could be co-
infected, which is similar to results for other viruses. For example, co-infection DF-1 cells with 
Newcastle disease viruses expressing RFP and EGFP resulted in 27% dual fluorescence (Li et 
al., 2012). For HIV-1, the co-infection frequency was only 2.3% in four different cell lines 
(Bregnard et al., 2012), but increased to around 40% when T lymphocytes were the target of 
superinfection (Dang et al., 2004; Levy et al., 2004).  
 
     Recombination within EGFP was studied by co-transfecting HEK cells with P129-
EGFP-97C and P129-EGFP-d(2-6) infectious clone plasmids. The P129-EGFP-97C infectious 
clone codes for a full-length virus that expresses a non-fluorescent mutant EGFP.  The 97C 
mutation was discovered by sequencing non-fluorescent EGFP genes cloned into the nsp2 region 
of PRRSV (Kim et al., 2007). During the formation of the fluorophore, arginine 97 stabilizes the 
carbonyl group of the imidazolidinone ring formed by Tyr-67/Gly-68. Together, all three amino 
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acids participate in the post-translational modifications needed for fluorophore formation. To 
obtain a fluorescent virus, recombination between the full-length and defective genomes would 
have to occur within the 426 nucleotides between site of the 97C mutation and the MluI 
restriction site (see Figure 5). Infected cells remained negative for EGFP fluorescence and 
positive for N protein staining after six sequential passages of the P129-EGFP-97C virus on 
MARC-145 cells. This demonstrated that the 97C mutation was stable and infectious virus was 
produced during each passage. The successful production of EGFP-97C protein was 
demonstrated by a dual staining experiment of P129-EGFP-97C-transfected HEK cells with anti-
GFP (green) and anti N-protein (red). Figure 9 shows cells that are simultaneously producing 
EGFP-97C and N protein. The stability of this mutation over serial passages cannot be tested in 
HEK cells because these cells although susceptible, are non-permissive to PRRS virus. The 
recombination frequency within the 426 nt region of EGFP was estimated to be 0.3%, a value 
consistent with the results of previous studies, which incorporated PCR as the means to identify a 
recombination event (van Vugt et al., 2001). For instance, the infection of MARC cells with two 
closely related Type I viruses revealed a recombination frequency of 0.1 to 2.5%  within a 621 nt 
region located between the 3’ end of ORF3 through the 3’ end of ORF5 (van Vugt et al., 2001). 
 
     EGFP and GFP gene sequences possess 124 mismatches or 83% identity at the 
nucleotide level (see Figure 1B). Within the 426 nt region where recombination was predicted to 
occur, there are 64 mismatches, with two 20 nucleotide stretches of identity.  Recombination was 
not detected between the GFP and EGFP-97C viruses. A 164 nt stretch of 100% identity was 
inserted 3’ of the 97C mutation to create the construct, P129-GFPm-d(2-6), see Figure 1B. Co-
transfection of this plasmid with the P129-EGFP-97C yielded a fluorescent virus. However, the 
recombination crossover site was located downstream of the 164 nt region of homology, within a 
second region that possessed a 20 nt stretch of homology (see Figure 8).  The same crossover 
region was identified in 6 of 6 clones in a population of infected MARC-145 cells selected for 
fluorescence. The mechanistic basis for the selection of this site remains to be determined.   
 
     Recombination between P129-EGFP-97C and EGFP was not detected when EGFP 
was expressed as a separate mRNA. One explanation for this negative result is that the EGFP 
mRNA, may not have access to double walled membrane vesicles, the location of virus 
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replication complexes (Pedersen et al., 1999). Therefore, the development of targeted 
recombination techniques for PRRSV and other arteriviruses may require the specific 
localization of the regions of interest to the virus replication complex. 
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Figure 3-1  PRRSV constructs used in this study. 
A. PRRSV P129 strain is the parent virus used to create the constructs shown below. This 
schematic representation shows the position of foreign gene (GFP, DsRed, EGFP-97C, 
EGFP, GFPm) to be between non-structural (ORF1) and structural (ORFs2-7) regions of 
the virus genome. The V-shaped line indicates a deletion in that region. B. White lines 
indicate nucleotide mismatches between GFP or GFPm with EGFP gene. 
 
The upper figure, A, shows the wild-type and defective viruses used in the study. Key: L, 
leader; UTR, 3’ untranslated region; p(A) poly A tail. The lower figure, B, shows the nucleotide 
sequence comparison between wild-type GFP and EGFP (upper panel) and GFPm and EGFP. 
The GFPm construct possess a 290 bp region of homology. 
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Panel A shows the schematic representation of the two infectious clones used for this 
experiement. Panel B shows the growth curves. Growth of P129-GFP (open circles) and P129-
RFP (closed circles) viruses was performed on MARC-145 cells. Viruses were prepared by 
transfection of HEK cells with plasmid cDNA followed by 6 passages on MARC-145 cells. 
 
A. 
 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-2 Growth curves for P129-GFP and P129-RFP viruses. 
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Panel A shows HEK cells co-transfected with equal quantities of P129-GFP and P129-RFP 
plasmids. The amount of each plasmid used for transfection was 0.27 μg . Panel B shows a single 
MARC cell at 48 hrs after co-infection with equal amounts of P129-RFP and P129-GFP viruses 
on MARC cells. Panel C shows a representative PAM cell at 24 hrs. after co-infection.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-3 Co-infection/transfection of cells with P129-GFP and P129-RFP viruses/plasmids. 
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Top panels show infection of MARC cells by individual viruses. Bottom panels show co-
infection of MARC cells using different ratios of viruses. The numbers are the percentage of 
cells in each quadrant. Data were collected at 48 hrs after infecting cells with an MOI of 10.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-4 P129-GFP and P129-RFP expression in MARC-145 cells. 
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Figure 3-5 Experimental design for traditional PCR method used for PRRSV 
recombination  
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Figure 3-6 Study design: in-vitro model for recombination 
 
A. Approach for new in-vitro model 
 
 
 
B. Experimental design for new in-vitro model 
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Figure 3-7 Recombination within EGFP during negative or positive strand synthesis.   
The figure shows a single recombination event within a 426 nucleotide region, which will 
replace the 97 cysteine mutation with arginine to yield a full-length fluorescent virus. 
Recombination occurs in HEK cells transfected with defective and full-length PRRSV infectious 
clone plasmids. The supernatant is used to infect MARC-145 cells. Successful recombination is 
detected by the presence of green fluorescence.  
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Plasmids were co-transfected into HEK cells. At 48 hrs after transfection, the supernatants were 
transferred to MARC cells. Cells were stained for N protein at 48 hr after transfection/infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-8 Recombination between P129-EGFP-97C and P129-EGFP-d(2-6). 
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Figure 3-9 Recombination between P129-EGFP-97C, P129-GFP-d(2-6) and P129-GFPm-
d(2-6). 
Individual plasmids were transfected into HEK cells and 48 hr after transfection, media 
transferred to MARC-145 cells.  Cells were fixed and stained for the presence of N protein at 48 
hr after transfection or infection. 
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The upper portion of the figure shows sequences for the parent viruses: EGFP-97C, GFPm and 
the recombined virus. The shaded region identifies the site of recombination. The lower figure 
shows the location of the recombination site.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-10 Single crossover event between P129-EGFP-97C and P129-GFPm-d(2-6) to 
yield a fluorescent virus.   
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Figure 3-11 Control experiments for the dual transfection and infection studies for 
recombination performed in this study. 
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Figure 3-12 Sequence comparison of marker region in parent and recombined viruses 
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Table 3-1 Frequency of recombinant viruses produced after co-transfection  
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Chapter 4 - Conclusion and application 
 
PRRS has become one of the most challenging diseases to the global swine industry from 
the time of its initial identification in the early 1990s. Extensive research and elimination 
programs have been undertaken to control the spread and losses caused by PRRSV. During the 
last 23 years, our understanding of this disease has increased tremendously in the areas of the 
virus biology, the factors that influence immunity and the genetic heterogeneity of the virus. 
Efficacies of the modified live and inactivated vaccines have not been found to be promising for 
control of the disease. Novel vaccine strategies are being developed to cope with the increasing 
economic burden caused by this disease globally (Huang and Meng, 2010). The vast genetic and 
antigenic heterogeneity in PRRSV are observed in the inter-genotype, intra-genotype and 
quasispecies diversity that have a major influence on vaccine efficacy. Point mutations and 
recombination drive the rapid divergence of this virus. Recombination is a less investigated 
source for genetic diversity in PRRSV. However, recombination results in greater evolutionary 
jumps as compared to point mutations. The research presented in this dissertation focused on 
understanding the molecular and cellular features of PRRSV recombination. 
 
Recombination in positive stranded RNA viruses has been most widely accepted to occur 
by a template-switch model (Lai, 1992, p. 199). The concepts of this model and several structural 
signals that influence this mechanism have been studied for RNA viruses that infect animals, 
plants and bacteria. These aspects have been discussed in detail in Chapter 2. A detailed 
literature review about recombination in PRRS virus showed that there are currently two 
methods to study recombination:  
(i) An in-vitro method that uses differential PCR amplification followed by 
sequencing of these amplicons to detect cross-over.  
(ii) An in-silico method that uses a range of different bioinformatic tools to analyze 
sequence datasets to detect recombination hotspots, cross-over patterns, and 
influence of nucleotide sequence and RNA secondary structure on 
recombination. The sequences used in these analyses are either from isolated 
viruses or PCR amplification products.  
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As discussed in Chapter 2 there are several constraints for a recombination event to result 
in a biologically relevant recombined virus.  However there are reports that indicate 
recombination to be responsible for emergence of a new Western Equine encephalitis virus 
(Hahn et al., 1988) and  for large-scale Chinese PRRSV outbreaks (Shi et al., 2013). Therefore 
while studying recombination it is important to focus on features of recombination events that 
result in viable viruses that are ‘fit’ to compete with the existing strains of parent viruses. In 
other words, detection of viable virus is important because such an observation would provide 
substantial amount of information regarding occurrence and significance of recombination 
events. The most critical limitation of currently available PCR detection methods is the lack of 
knowledge regarding the viability of the virus carrying the recombined region. This is because 
PCR amplification can use genomic, subgenomic or defective RNA strands as templates. 
Therefore the primary objective of this research was to develop a simple in-vitro model system 
that would generate viable recombined viruses. To demonstrate the usefulness of this system, 
recombination frequency was compared to previous data in literature.  This in-vitro system 
creates quantitative estimates of parameters to predict the occurrence of recombination. To 
demonstrate this property the system was applied to elucidate how the degree of nucleotide 
sequence homology influences cross-over. Another application of this system was made to gain 
insight in to the localization of recombination event in a PRRSV infected cell.  
 
Future applications of the in-vitro system 
 
The experiments in this project showed that GFPm gene was synthesized and cross-over 
was studied in a specific 164 bp region. In a similar manner, a number of modifications 
involving synonymous and non-synonymous mutations can be made in EGFP/GFP genes to 
study influence of various nucleotide features on the mechanism of cross-over. The incorporation 
of GFP gene as the target for recombination creates the opportunity to easily make mutations in 
this gene as it is non-essential for virus replication. One of the important features of this system 
is the absence of selection pressure. This will help simulate recombination events in the absence 
of artificial selective conditions.  
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One of the implications in a previous study was that recombination is favored when short 
homologous stretches are flanked by longer regions of high degree of identity (van Vugt et al., 
2001). The copy-choice mechanism proposed by Lai et al., 1991 also suggests that longer 
stretches of sequence alignment would enable the nascent RNA transcript to bind and orient the 
RNA polymerase complex to continue synthesis after switching templates (Lai, 1992). Our study 
also showed that increasing the length of identical stretches promotes recombination. Similarly 
the effect of flanking region homology on recombination can be determined by sequentially 
incorporating ORF2 to ORF5 in the infectious clone P129-EGFP-d(2-6). The influence of the 
increased flanking region homology should be evident on the measured recombination 
frequency. Variable rates of recombination between the 5’ and 3’ proximal regions were 
observed in case of Equine Arteritis Virus (EAV).  It was demonstrated that the 5’ end of the 
genome had about 100-fold lower recombination rate as compared with the 3’ structural region 
(Molenkamp et al., 2000a).  Similarly, the recombination frequency in the spike gene in the 
coronavirus MHV was three times greater than that in the replicase gene (Fu and Baric, 1992).  
A similar analysis can be performed for the PRRSV genome using the in-vitro system.  For this 
purpose recombination in the non-structural (ORF1) and structural (ORF2-7) regions can be 
compared. Two different studies have shown the occurrence of recombination in Nsp2 region of 
ORF1a which is at the 5’ end of the genome. In the in-vivo study done by Dan Liu et al 2011 
about 27% recombinants were found to have cross-over in the nsp2 region and 14 different 
cross-over sites were detected. Phylogenetic analysis of the field strain Em2007 from China 
showed that this strain was a recombinant between a field and vaccine strain with 2 cross-over 
sites in Nsp2 region (Li et al., 2009a).  Nsp2 is of interest in the study of virus evolution and 
pathogenesis (Han et al., 2006; Shen et al., 2000) as it is the largest non-structural protein and is 
multi-functional in nature. Nsp2 has a N-terminal cysteine protease domain that is essential for 
the processing of pp1a encoded by ORF 1, possesses de-ubiquitinating and immunomodulatory 
functions  (Fang and Snijder, 2010).  However, despite the critical functional roles of this protein 
it is the most variable region in the entire PRRSV genome. Natural deletions and insertions are 
frequently observed in this region. Insertion of EGFP gene in the Nsp2 region in the defective 
virus and EGFP-97C gene in the full length infectious virus will give insight into the occurrence 
of recombination in the Nsp2 region. Comparison of the frequency of recombination in this 
experiment and with EGFP inserted between ORF1 and ORF2 would give an estimate of 
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frequency of recombination at the 5’ and 3’ end of the PRRSV genome.  The in-vitro system will 
not only improve our basic understanding of PRRS virus biology but also can be applied to 
investigate other RNA viruses. 
 
Several studies have shown strong evidence of RNA structure to influence the location of 
recombination hotspots and recombination frequency (Dedepsidis et al., 2010; Simon-Loriere et 
al., 2010). The in-vitro system developed in this research can be used to study this aspect of 
recombination. Comparison of maps of RNA secondary structure of EGFP, GFP and GFPm 
could possibly contribute to some insights regarding the preference of 3’ 20 bp region for cross-
over. The in-vitro system will enable predictions for successful recombination events based on a 
better understanding of nucleotide sequence features that influence cross-over. These predictions 
include recombination between field viruses, between genotypes and, between field and vaccine 
strains. In case of DIVA (differentiating infected from vaccinated animals) vaccine strategy, 
this system can be applied to study if DIVA markers will be eliminated from the vaccine strain 
or acquired by the field strains by recombination. Recombination in the DIVA marker region is a 
significant problem because it can lead to failure of this vaccination approach. Isolation of viable 
recombined viruses resulting from cross-over events between vaccine and field strain have been 
detected in a number of studies from Britain and China (Frossard et al., 2013; Li et al., 2009a; 
Wenhui et al., 2012). MLV vaccine is used extensively in the field for the control of PRRS and 
hence the potential for recombination with field strains is a significant concern. The infectious 
clones P129-EGFP-97C and P129-EGFP-d(2-6) can be used as backbone viruses where non-
structural and/or structural genes of vaccine strain and particular field strains can be incorporated 
to predict the chances of recombination among them. Such data will also be useful for designing 
multi-strain vaccines for PRRSV control.  Recombination can lead to genetic shift resulting in 
viruses with new phenotypic features that may lead to increased pathogenesis. This in-vitro 
system can be applied to predict emergence of novel variants of the virus arising due to such 
genetic shifts. 
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